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1. INTRODUCTION 
The object of this dissertation project is to examine two 
chemically modified human hemoglobin (Hb) species by the 
method of X-ray crystallography. The modification of Hb by 
cross-linking in each case was done in order to examine its 
potential as a viable red cell substitute. However, the tests 
performed to determine the efficacy of the blood substitute 
will not be within the scope of this project. 
A number of multi-functional cross-linking reagents have 
been examined as chemical stabilizers of the Hb molecule (1-
6). Of these, the cross-linker bis (3, 5 dibromosalicyl) fumarate 
(DBSF) has been the most popular and has been used under a 
variety of reaction conditions depending on where on the 
protein molecule the modification was aimed. These modified 
Hb species are then tested for stability, oxygen affinity, and 
rate of auto-oxidation (7,8) and the values for these 
parameters are compared to those for normal, whole blood. To 
check for differences after modification of the protein, to 
be able to explain these differences, and so to suggest 
1 
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methods to minimize these differences, it is necessary to be 
able to view the structure of the derivatized molecule and be 
able to compare it with that of the native protein. such a 
process of structure elucidation by the experimental technique 
of protein crystallography and subsequent analysis of the 
cross-linked structure is detailed in the body of this 
dissertation. 
1.1 Red Cell Substitutes 
A life sustaining oxygen-carrying fluid would have many 
clinical demands. The need to develop such a fluid is now 
urgent because of the increasing concern over blood-
transmitted viral and bacterial pathogens (9). Also, there 
are several antigenic systems which need to be taken into 
account when matching blood types and it can take a fairly 
long time to cross-match these different types. Even if 
properly cross-matched, blood has a limited use because of its 
short storage life, which at present does not exceed 35 days 
(10), unless kept frozen. Blood is also difficult to transport 
because it must be stored at 4 °C. 
Of the several potential acellular oxygen carriers, those 
of hemoglobin derivatives have been studied very extensively. 
Stroma-free hemoglobin solution has properties which suggest 
that it might be a substitute for the red cells. Its 
advantages are (11): 
1. high solubility in physiological solutions; 
3 
2. the ability to take up oxygen; 
3. a colloidal osmotic pressure equal to that of whole blood; 
4. stimulation of hemopoetic tissue. 
There are two principal problems that need to be overcome 
to utilize hemoglobin as a red cell replacement. First, the 
derivative must be modified by cross-linking to prevent 
dissociation of the tetramer. Oxyhemoglobin readily 
dissociates into a~ dimers, which with a molecular weight of 
only 32,000, escape through the kidneys (12). This leads to 
a rapid rate of clearance of hemoglobin from circulation, and 
the massive hemoglobinuria that results poses the risk of 
renal injury. Secondly, the absence of 2, 3-bisphosphoglycerate 
(BPG} results in an increase in the oxygen affinity of 
hemoglobin thus limiting the unloading of oxygen to the 
tissues. Under physiological conditions, the P50 (partial 
pressure of oxygen at half saturation of hemoglobin} of 
isolated hemoglobin A is approximately 12 mm Hg, compared to 
26 mm Hg for whole blood (13). As a result, the amount of 
oxygen released by hemoglobin at the normal tissue partial 
pressures of oxygen (approximately 40 mm Hg} is decreased by 
nearly half. 
Several bifunctional reagents have been examined as 
cross-linkers that would covalently link the hemoglobin 
subunits thereby preventing them from dissociating into dimers 
in solution. Glutaraldehyde is one such cross-linker used to 
prolong the intravascular retention time of hemoglobin (14-
4 
17). This reagent is, however, nonspecific which leads to a 
high level of modification. This often leads to problems of 
antigenicity and can increase the propensity of the hemoglobin 
toward auto-oxidation. Isolation of pure species can be 
difficult after the reaction has occured because of the 
formation of a heterogeneous mixture of derivatives. Only a 
selected molecular weight range can be isolated. Also, the 
oxygen affinity of derivatives following random cross-linking 
is frequently increased, which is the opposite effect of what 
is desired for use of the derivative as a red cell substitute 
{18). Pyridoxal phosphate and other polyanionic affinity 
reagents that react with hemoglobin at the BPG binding site 
have been used to lower the oxygen affinity of such 
derivatives (14-17, 19). 
Another bifunctional analog 2-2-formyl-pyridoxal 5'-
phosphate was used (20-22) to cross-link the hemoglobin 
tetramer between the fi subunits and reduce the oxygen 
affinity. This cross-linker is, however, difficult to 
synthesize making it unfeasible to prepare this derivative in 
large amounts needed for clinical use. 
Bis(3,5-dibromosalicyl) fumarate belongs to a class of 
acylating affinity reagents that react to cross-link 
hemoglobin, Figure 1. Its specificity differs depending on 
whether the reaction is carried out under oxy or under deoxy 
conditions. Under oxy conditions DBSF reacts selectively to 
cross-link the fi chains between Lys-82fi 1 and Lys-82fi 2 within 
5 
Figure 1. Reaction of DBSF with HbA. Cross-linking is between 
Lys-p82s under oxygenated conditions, and between Lys-a99s 
under deoxygenated conditions. 
6 
deoxy oxy 
Lysa. 99- NZ- XL- NZ-Lysa. 99 I 2 Lys 13 82- NZ- XL- NZ -Lys ~ 82 I 2 
0 0 
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the 2,3-bisphosphoglycerate binding site (23,24). 
7 
The 
preferential reactivity of DBSF within the~ cleft is directed 
largely by the electrostatic and hydrophobic nature of the 
cleft region (25). DBSF has bridging groups of 4 carbon atoms 
and is 5.8 A in length. However, the distance between the two 
~82-Lysines is around 9.10 A in oxyhemoglobin. This would 
imply a considerable movement of the two lysines into the 
cleft regions when cross-linked. Structural studies on this 
modified hemoglobin include a X-ray crystal structure 
extending to a resolution of 4.4 A (23). These studies implied 
that the overall quarternary structure of both the liganded 
and the deoxy forms is identical to that of native hemoglobin 
(23,24) and that the cross-linked hemoglobin remains highly 
cooperative, with only a slight increase in oxygen affinity 
(23,26). 
Under deoxy conditions DBSF cross-links the two a 
subunits of hemoglobin, but with much lower yield (27). The 
cross-linking bridge lies between Lys-99a1 and Lys-99a2 and 
spans the central cavity of the hemoglobin tetramer. Lys-99a1 
and Lys-99a2 lie within a cluster of charged residues making 
the attraction of the cross-linker to this area very much like 
the~ cleft region in oxy hemoglobin. In oxyhemoglobin this 
site is completely inaccessible to the reagent. This 
hemoglobin derivative too remains highly cooperative despite 
the cross-link. The Bohr effect is altered greatly; up to more 
than 50%. The 3.5 A crystal structure (27) suggests that in 
8 
the cross-linked derivative Glu-lOlfi, which is closely 
associated with Lys-99a in oxyhemoglobin becomes an acid Bohr 
group. The oxygen affinity here is lowered and the P50 of the 
a99XLHbA is around 29.0 mm Hg compared with 13.9 nun Hg for 
native hemoglobin. From this information the lower oxygen 
affinity of the a,a-cross-linked hemoglobin could be 
attributed to stabilization of the native T-state conformation 
due to subtle changes in deoxyhemoglobin structure that could 
not be noticed at the resolution of the X-ray structure, or 
to altering the quarternary transition during ligand binding. 
These and other properties of a99XLHbA make it a very likely 
candidate for a viable blood substitute. 
1.2 The nature and function of Hemoglobin 
Hemoglobin is a globular protein molecule with a four 
subunit quarternary structure, Figure 2. Two of these subunits 
have identical primary structures with 141 amino acids each 
and are called the a subunits. The other two fi subunits are 
also with identical amino acid sequences and have 146 amino 
acids each. The entire protein has a molecular weight of 
64,500. As in other proteins, the polypeptide chain of each 
subunit has a complex folded structure - two thirds of which 
is arranged in seven and eight helices of the a and fi chains 
and are labeled from A to H. These helices, stabilized by 
hydrogen bonds, vary from seven to twenty 
9 
Figure 2. Backbone sketch of the Hemoglobin Tetramer. The two 
a chains are in darker lines and the two p chains are the 
lighter lines. 
10 
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residues in length with 3.6 residues per turn of helix. The 
a-helix pattern of the protein is interrupted at specific 
locations by segments lacking helical conformation. 
As with many other proteins, hemoglobin incorporates 
within its structure a prosthetic group that is largely 
responsible for its functional properties, Figure 1.3. This 
is a macrocyclic ring system of four pyrrole rings and is a 
porphyrin structural variant synthesized by living systems. 
The ring chelates to an iron atom. This porphyrin-iron complex 
is termed the heme prosthetic group. The iron atom can 
potentially have several oxidation states, but the Fe2+ form 
is the one that binds to oxygen. The heme group is present in 
each of the four subunits. 
Hemoglobin, which is contained in the red blood cells of 
vertebrates, serves as the oxygen carrier in blood and is also 
involved in a major way in the transport of carbon dioxide and 
hydrogen ion. The iron atom of the heme can make two 
additional bonds on either side of the heme plane. One of 
these bonds is made with the nitrogen atom from the imidazole 
ring of a histidine residue which is known as the proximal 
histidine, Figure 3. It is the 87th residue of the a chain 
and the 92nd residue of the~ chain. The sixth and last bond 
that the heme iron makes is with oxygen in oxyhemoglobin. This 
position is vacant in deoxyhemoglobin. However, in its 
vicinity is another imidazole ring of what is termed the 
12 
Figure 3. Heme group with proximal, His-~92, and distal, His-
~63, histidines on the ~ chains. The N,2 of His-~92 bonds 
directly to the Fe of the heme while His-~63 is positioned 
only to preserve spatial relationships in deoxy HbA. 
13 
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distal histidine residue which is considered important in 
maintaining spatial relationships (28). In oxyhemoglobin the 
N, of the distal histidine is hydrogen bonded to the oxygen 
bonded to the heme iron (29). Besides transporting oxygen, the 
heme group helps stabilize the globin chain and increases the 
solubility of the protein. 
The hemoglobin tetramer is organized as two a,B dimers, 
with the a 1,B 1 subunits in one dimer and the a 2,B 2 in the other 
(30). The subunits making up the dimers are held tightly 
together; the dimers themselves are capable of motion with 
respect to one another. The two dimers are related by a two-
fold axis of symmetry. The individual subunits too are 
arranged with approximate 222 symmetry, Figure 4. The 
interface between the two movable dimers contains a network 
of salt bridges and hydrogen bonds when hemoglobin is in the 
deoxy conformation (31). On binding to a ligand like oxygen 
a transformation in the quaternary structure takes place which 
results in breakage of these bonds. 
The tetramer ic structure of hemoglobin, due to the 
association of the four globin chains, leads to its various 
properties and functions like the Bohr effect (32,33), 
cooperativity ( 3 4) , the 2,3-bisphosphoglycerate effect 
(35,36), and suitable oxygen affinity so that tissue oxygen 
requirements can be met. There are four areas of contact 
between the subunits: a 1,B 1 , a2{3 2 , a 1{3 2 , and a 2{3 1 • The a 1{3 2 and 
the a2{J 1 regions are weaker than the a 1{3 1 and 
15 
Figure 4. Hemoglobin quarternary structure showing the two-
fold axis - with a solid line that relates one ap dimer to the 
other. There is also approximate 222 symmetry due to the 
pseudo two-folds as shown by the dashed line. 
16 
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the a 2p2 contacts and allow movement during oxygenation. This 
movement leads to hemoglobin existing in at least two 
different quaternary conformations, corresponding to the oxy 
and deoxy states. These two structures are described by X-ray 
crystallography as the R (for relaxed) and bound to oxygen and 
the T (for tense) and deoxygenated (37,38). Because of the 
movement along the a 1p2 interface, the contacts are entirely 
different in deoxyhemoglobin compared with oxyhemoglobin. 
Under physiological conditions oxyhemoglobin dissociates 
reversibly into like dimers (39): 
(ap) 2 = 2ap 
This is due to the fewer interactions between the a 1p1 - a 2p2 
interface (39). Moreover, isolated hemoglobin chains are less 
stable than the fully associated tetramers. Therefore, the 
regions of contact between them are important in maintaining 
normal solubility. The central cavity of hemoglobin is filled 
with solvent and allows the entrance of charged molecules that 
affect its molecular function, like BPG and salts, Figures 5a 
and 5b. 
1.3 X-ray Studies 
The two modified hemoglobin species, one cross-linked 
with DBSF between the two p-82 lysines, and the other between 
the two a-99 lysines have both been previously characterized 
to a modest extent by X-ray crystallography (23,27). 
18 
Figure 5. (a) Region of the Lysines-a99 showing the solvent 
filled cavity, and (b) the p-cleft region, the BPG binding 
site, and with two Po/- ions. This view shows the positive 
charges lining this site. The two His-Pl, the two Val-Pl, the 
two Lys-pa2 and the two His-p143 contribute a total of eight 
positive charges. The BPG with its five negative charges sits 
in the middle of this ring of positive charges. 
19 
(a) 
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1.3.1 Initial studies on fi82XLHbA 
Crystals of fi82XLHbA cross-linked with DBSF and bis(J,5-
dibromosalicyl) succinate (DBSS) were grown in the deoxy form 
according to the procedure described by Perutz ( 40) for 
deoxyhemoglobin A. Diffraction data were collected on an 
Enraf-Nonius CAD4 diffractometer to a resolution of 4. 4 A 
using the omega scan mode. Difference electron density maps 
were calculated using the known phases of deoxyhemoglobin A 
( 41) and the difference amplitudes (IF I modified HbA - IF I HbA) , and 
then symmetry averaged about the molecular 2-fold axis (42). 
The lengths of the unit cell edges for crystals of the cross-
linked hemoglobins were not substantially different from those 
in crystals of deoxyhemoglobin A; there was, however, a 
significant increase in the fi angle, Table 1. A theoretical 
analysis by Crick & Magdoff (43) indicated that at higher 
resolution (<3 A) such a change in the fi angle could lead to 
large changes in intensity. Therefore the study was limited 
to the resolution of 4.4 A. 
Table 1. : Unit Cell Constants (space group P2 1 ) (27) 
Hemoglobin 
HbA 
DBSS-HbA 
DBSF-HbA 
a(A) b{A) c(A) ,B(deg) 
63.2 83.5 53.8 99.3 
63.2 83.4 53.5 100.0 
63.2 83.4 53.6 99.6 
Resolution 
1.1 A 
4.4 A 
22 
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The difference Fourier maps calculated between cross-
linked and native hemoglobin revealed only slight changes in 
the modified protein (23). The only region of the difference 
map at which chemical modification was observed was at the BPG 
binding site perpendicular to the 2-fold axis of the tetramer. 
The cross-link bridge was observed as a band of positive 
difference density, 1. 5*a, that connects the two f3 chains 
between Lys-82{3 1 and Lys-82{3 2 • Other interesting features were 
observed in the region of the EF corner and the F helix on the 
difference map as a series of alternating peaks of negative 
and positive difference electron density. These were 
interpreted as being due to a shift of these portions of the 
molecule, relative to their positions in the native structure, 
toward the central cavity of the tetramer. Apart from this 
local perturbation, no other differences were observed in the 
overall quarternary structure between the cross-linked and 
native deoxyhemoglobin A in the difference map. This apparent 
shift in the EF and F helices is explained by the fact that 
while the cross-linking is performed under oxy conditions when 
hemoglobin is in the R quarternary conformation, the crystals 
were grown under deoxy conditions. Under the oxy conditions 
of the cross-linking the cross-linker can span the distance 
Lys82 of each f3 chain with little or no distortion of the 
protein structure. However, upon deoxygenation when crystals 
are grown the change in conformation leads to an increase in 
the separation of the f3 chains (44,45). The cross-link then 
24 
provides a constraint upon the EF corner and portions of the 
F helix so that these regions cannot move apart to the full 
extent that normally would occur upon deoxygenation. 
Therefore, in the deoxy form of the cross-linked hemoglobin 
these regions appear shifted toward the central cavity of the 
tetramer, as observed in the electron density maps. 
1.3.2 Initial studies on a99XLHbA 
Under deoxy conditions when hemoglobin is in the T 
quarternary conformation, the~ chains move farther apart 
(44,45) and cross-linking between them is not possible with 
a cross-linker spanning the length of DBSF. 
these conditions the two Lys-99 of the a 
However, under 
chains become 
accessible to the cross-linker and the distance between them 
is comparable to the length of DBSF. X-ray studies on the 
hemoglobin cross-linked under deoxy conditions show that the 
cross-link lies between Lys-99a1 and Lys-99a2 , spanning the 
the central cavity of the hemoglobin tetramer. Lys-99a1 and 
Lys-99a2 lie within a cluster of charged residues very near 
the middle of the hemoglobin molecule. 
Crystallographic studies on the deoxy a99XLHbA derivative 
were performed with data collected to a resolution of 3.5 A 
to locate the site of the cross-link and to determine the 
effects of this modification on the structure of the protein 
(27). The cross-linked derivative was crystallized in the 
deoxy form as for native deoxyhemoglobin A (40). The 
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difference electron density map was calculated using phases 
from a 2.5 A refinement of deoxyhemoglobin A (43) and the 
measured amplitudes. Since the map showed a very high degree 
of 2-fold symmetry it was averaged about the molecular dyad 
that relates the a~ dimers. The only portion of the difference 
electron density map that indicates any changes between the 
cross-linked and native hemoglobin is in the area of the 
cross-link. The two intense peaks over Lys-99 of each a chain 
were thought to be due to the cross-link. There was no 
electron density observed in the middle of the cross-link 
bridge in the difference map. This was explained by assuming 
that the electron density in the central portion of the cross-
link was similar to that of the solvent background which may 
have resulted in the displacement of water molecules by the 
cross-linker during binding. Another explanation was that the 
lack of difference density near the center of the cross-link 
resulted from the mobility of the fumaryl group due to 
rotational freedom of the lysine side chains. 
Other features observed from the difference density map 
suggested some movement of residues within the central cavity 
neighboring the cross-link. The side chain of Glu-101~ 
appeared to have moved toward the cross-link and associated 
itself with the amide group of the cross-link. No other 
indication of a displacement of the polypeptide backbone at 
Lys-99a or any of the adjacent residues was evident from the 
difference electron density map. 
2. STATEMENT OF RESEARCH 
This project proposes to examine the molecular structure 
of two chemically cross-linked hemoglobins by X-ray 
crystallography at high resolution. One is cross-linked 
between the two Lys-82 of the two p chains under oxy 
conditions, though crystals were grown as for deoxyhemoglobin 
A. The second is cross-linked between the two Lys-99s of the 
two a chains under deoxy conditions and the crystals were 
grown under deoxy conditions. 
Three Dimensional Structure 
The X-ray structures of both P82XLHbA and a99XLHbA have 
been solved before (23,27). However, they are both at 
relatively low resolution; a resolution of 4.4 A in the case 
of P82XLHbA and a resolution of 3.5 A in the case of a99XLHbA. 
High resolution structures would provide deeper insights into 
the mechanism of binding of the cross-linker to the protein, 
and a deeper understanding of the properties of the modified 
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protein. 
1. The 4.4 A resolution data set in the case of ~82XLHbA 
provides proof of the cross-linking site. It, however, 
provides little else. The conformation of either the residues 
in the vicinity of the modification site or of the cross-
linker cannot be determined at such low resolution. 
2. While a high resolution, 1.74 A, structure of native 
hemoglobin is available (46), there is no correspondingly high 
resolution structure of the modified protein. Consequently, 
studies using protein modeling and dynamics to study the 
mechanism of the reaction of the cross-linker are less 
reliable without accurate 'before' and 'after' structures. 
3. The same is true with the a99XLHbA derivative since 
the only three-dimensional structure extends only to a 
resolution of 3.5 A (27). Since cross-linking between the a 
chains lowers the oxygen affinity of the derivative compared 
to that of native hemoglobin A, the lower oxygen affinity 
could be attributed to stabilization of the native T-state 
conformation (47) and small changes in the cross-linked 
hemoglobin or by altering quarternary transition during ligand 
binding. At this resolution, subtle changes in the deoxy 
hemoglobin structure that affect oxygen binding cannot be 
determined. 
4. In this study crystals of both ~82XLHbA and a99XLHbA 
have been grown. crystals of ~82XLHbA were grown out of PEG-
6000, inspired by the PEG-6000 crystal structure of Silva et 
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al. (48) with diffraction data extending to a resolution of 
about 2.2 A. Crystals of a99XLHbA grown from solutions of high 
salt (40) yielded diffraction data extending to 1.9 A. The 
dissertation will examine the molecular structure of these two 
hemoglobin derivatives by X-ray crystallographic methods. The 
physiological implications of the modification will be 
analysed from these molecular structures. 
3. MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Chemicals and Supplies 
Life Source 
Packed Red Blood Cells 
Baxter Blood Substitutes, Deerfield, IL USA 
a99XLHbA, hemoglobin cross-linked between Lys-a199 and 
Lys-az99, Lot #94D01AD11-051394. 
Sigma Chemical Company, St. Louis, MO, USA 
Tris (Tris(hydroxymethyl) aminomethanehydrochloride) 
MOPS (4-morpholinepropane sulfonic acid) 
Sodium azide 
Dalton Mark VI SDS molecular markers 
Coomasie blue 
J. T. Baker Chemical Company, Phillipsburg, NJ, USA 
Sodium phosphate, dibasic 
Sodium phosphate, monobasic 
Sodium cyanide 
Ammonium sulphate 
Sodium hydroxide 
Potassium phosphate monobasic 
Ammonium phosphate monobasic 
Ammonium phosphate dibasic 
Mallinckrodt, Inc., Paris, KY, USA 
Potassium phosphate, dibasic 
Sodium Chloride 
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Fisher Scientific Company, Pittsburgh. PA, USA 
Sodium hydrosulfite (sodium dithionite) 
Polyethylene glycol (PEG-6000) 
Hydrochloric acid 
Pharmacia LKB Biotechnology, Uppsala, Sweden 
PhastGel Homogenous 12.5 SOS gel 
PhastGel SOS buffer strips 
Pharmacia Fine Chemicals Inc., Piscataway, NJ, USA 
DEAE-Sephadex A-50 gel 
Gelman Sciences Inc., Ann Arbor, MI, USA 
0.2 micron filters 
Charles Supper Company, Natick, MA, USA 
0.7 to 1.5 mm Quarzkappillaren 
Polaroid high speed 4x5 instant sheet film 
Eastman Kodak Company, Rochester, N.Y., USA 
X-ray film (Kodak no-screen film, NS-5T) 
Developer and replenisher 
Stop-bath 
Fixer 
American Art Clay Co., Inc., Indianapolis, IN, USA 
Permoplast modeling clay 
3.1.2 Instruments 
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Instruments used: Hewlett-Packard (HP) 8451 UV-VIS diode 
array spectrophotometer, HP-7 4 7 0A plotter, HP-9121 disc drive, 
Orion research digital pH meter, water bath (Blue M Electric 
Co.), PHAST-System Separation and Control unit {Pharmacia), 
ISCO gel scanner model 1312, ISCO Tris peristaltic pump, 
Sorvall RC-SB refrigerated superspeed centrifuge (Dupont), 
small centrifuge 5414 
chromatography columns 
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(Eppendorf), Eppendorf pipettes, 
(Bio-Rad Lab.), clinical-gel 
electrophoresis equipment (Corning Medical). 
3.1.2.1 Equipment for Crystallography 
Enraf Nonius Diffractis Generator, Type Y 925 Integrating 
Precession Camera for precession film data collection. 
Xentronics Multiwire Area Detector mounted on a Huber 4-circle 
(511/424) Goniostat, at Argonne National Laboratory, Argonne, 
IL. 
Rigaku RU-200 (12kW) Rotating Anode Generator producing Cu Ka 
x-radiation. 
An R-AXIS II image plate detector using Fuji imaging plate 
technology for measurement of single crystal X-ray diffraction 
data, at Abbott Laboratories, Abbott Park IL. 
3.1.3 Computers 
VAX-VMS 8530 main-frame. 
Silicon Graphics Indigo (Silicon Graphics Inc., Mountain View, 
CA, USA). 
3.1.4 Computer Programs 
R-axis II data processing software (49), written for X-ray 
diffraction data acquisition and reduction. 
PROTEIN (50), a program for the crystal structure analysis of 
proteins, version October 1985. This program was installed on 
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the VAX-VMS and is written in FORTRAN IV. The tasks carried 
out by the program were: 
1. Generation and expansion of data files with reflection 
data. 
2. Scaling of reflection data. 
3. Averaging the reflection data and elimination of 
inaccurate or wrong measurements with calculation of R-values 
describing the quality of the measured data. 
4. Scaling of derivative data. 
5. Calculation of structure factors from atomic 
coordinates. 
6. Calculation of figure of merit, completeness of data 
and crystallographic R-value. 
7. Calculation of Fourier and difference Fourier maps 
using both normal and fast Fourier transform. 
8. Listing and peak searching of 3-dimensional maps. 
MERLOT (51), version 2.3, is a package of programs for 
implementation of the Molecular Replacement method of 
structure determination. The initial phases for the unknown 
molecule are obtained by orienting and positioning a model of 
the known structure in the unit cell of the unknown structure. 
The programs here assist in the determination of the angles 
and translations that can best position the model to match the 
structure of the unknown. The program is installed on the VAX-
VMS and is written in FORTRAN-77. 
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X-PLOR (52), version 3.1, is a refinement program based on an 
energy function approach; combining empirical, geometric and 
effective energy terms that describe experimental data. To 
determine three-dimensional structures of macromolecules the 
combined energy terms are minimized by gradient descent, 
simulated annealing, and conformational search programs. The 
X-ray crystallographic diffraction data are combined with 
molecular dynamics in a structure refinement process (53). The 
program is written in standard FORTRAN-77 and is installed on 
the Unix based Silicon Graphics Indigo. 
TNT (54), release 5-D, is a refinement program used to refine 
x-ray crystallographically determined structures with the x-
ray diffraction data as the restraint. The TNT package uses 
gradient descent methods to optimize the parameters of the 
molecular model. The methods used are of steepest descent and 
conjugate direction. The program is written in FORTRAN-77. 
PHASES ( 55) , is a package of programs designed for the 
processing and analysis of diffraction data. This program 
package was used primarily to compute structure factors and 
electron density maps. The program is written entirely in 
FORTRAN-77. 
CHAIN (56), version 5.0, is used to display atomic coordinates 
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and electron density maps on graphics systems and then to fit 
the atomic model to the electron density. After preparing data 
files containing the desired coordinate and density 
information the program then displays the electron density 
contour levels, superimposed with atomic coordinates on the 
screen. The program is installed on the Silicon Graphics 
Indigo. Density maps from X-PLOR are read directly by CHAIN. 
3.2 Methods 
3.2.1 Source and Isolation of Hemoglobin 
3.2.1.1 Separation from Red Blood Cells 
Hemoglobin was isolated as in the method of Dozy et al. 
(57) from outdated packed Red Blood Cells (RBCs) obtained from 
Lif eSource. The RBCs were washed with phosphate buff er saline, 
PBS. PBS was prepared by titrating 5 mM dibasic sodium 
phosphate (Na2HPO4 } to pH 8. o with 5 mM monobasic sodium 
phosphate (NaH2PO4}. To the resulting solution was added 8.77 
g NaCl per liter (150 mM). To every 20 ml packed cells 80 ml 
PBS were added and the mixture was stirred slowly. This 
solution of RBCs was then centrifuged at 3,000 rpm (l,075xg) 
for 10 minutes at 4 °C in a Sorvall RCSB refrigerated 
superspeed centrifuge using a SS-34 rotor. After 
centrifugation the supernatent and huffy coat were removed by 
35 
aspiration. Similar washings of the RBCs were performed two 
more times to ensure that the RBCs were free from any plasma 
materials. 
After washing the erythrocytes were lysed in 40 ml ice 
cold deionized water with gentle stirring for 30 minutes at 
4 °c. 20 ml cold neutral ammonium sulphate, AS, were added to 
every JO ml hemoglobin solution. Neutral AS was prepared by 
adding 76.7 g AS to 100 ml deionozed water and the pH adjusted 
to 7. 0 with 6. o M sodium hydroxide. The hemoglobin - AS 
mixture was stirred continously for 30 minutes at 4 °C. The 
mixture was then centrifuged at 12,000 rpm {17,210xg) for 10 
minutes. After centrifugation the hemolysate supernatent was 
pooled and saved. The residue containing membrane material and 
other precipitates was discarded. The hemolysate was desalted 
of the AS by extensive dialysis against a buffer of 0.05 M 
Tris, 1 mM NaCN and pH 8.5. The dialysis buffer was replaced 
frequently with fresh samples of the same. To ensure complete 
desalting the dialysis buffer was tested with 1 M BaC12 for 
formation of BaSO4 • The dialysis was continued until no such 
precipitate formation was noticed. The hemolysate was then 
considered fit for purification by ion-exchange 
chromatography. 
3.2.1.2 Purification by Ion-Exchange Chromatography 
Purification by chromatography was performed by the 
method of Huisman and Dozy (58) and Dozy et al. (57). DEAE 
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Sephadex A-50 gel was swollen in 0.05 M Tris, 1 mM NaCN, pH 
8.5 buffer at room temperature for two days. The A-50 was then 
packed into a chromatographic column and equilibrated with the 
0.05 M Tris, 1 mM NaCN, pH 8.5 buffer until the pH of the 
eluent was the same as that of the buffer. The dialysed 
hemolysate was then applied to the column top. Separation and 
subsequent elution of pure hemoglobin A was effected by using 
a decreasing pH gradient in the mobile phase. The gradient was 
from pH 8.5 to pH 7.2. The pH gradient system was prepared by 
filling two aspirator bottles with the buffer at the two 
different pH values mentioned above. These bottles were 
connected to each other by a tube running from the bottom of 
one to that of the other. A delivery tube ran from the bottle 
with the buffer at the higher pH to the top of the 
chromatography column. As the buffer in the higher pH bottle 
was depleted, it was gradually replaced with buffer from the 
low pH bottle. This resulted in a slow but linear decrease of 
mobile phase pH. Flow rate of the mobile phase was kept at a 
constant rate using an ISCO peristaltic pump. The hemoglobin 
fractions eluted out were monitored by an ISCO UA-5 absorbance 
monitor from 280-310 nm. 
3.2.1.3 concentration of Hemoglobin using the Pro-Dicon 
The purified hemoglobin was concentrated to the desired 
concentration using a Pro-Dicon after dialysis in the 
appropriate buffer. The Micro-ProDicon tubing was obtained 
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form Bio-Molecular Dynamics. The Pro-Dicon was filled with 
buffer up to a level of two inches from the top. Vacuum was 
applied from a water aspirator for one hour. The Pro-Dicon was 
then placed in the refrigerator till the volume of hemoglobin 
decreases to approximately yield the concentration desired of 
around 0.2 mM. 
3.2.2 cross-linking of Hemoglobin with Bis(3,5-
Dibromosalicyl) Fumarate 
3.2.2.1 Cross-linking between Lysine-99a1 and Lysine-99a2 
Cross-linking of hemoglobin between the two a 99 lysines 
was carried out with deoxy hemoglobin in 0.01 M MOPS, 1 mM 
NaCN buffer at pH 7.0 by purging hemoglobin in a flask at 4 
~C with a slow stream of wet nitrogen for around 4 hours, so 
that any oxy hemoglobin present was converted to the deoxy 
form. The change is observed as the bright red oxy hemoglobin 
turns to a purplish red deoxy hemoglobin. To this hemoglobin 
solution is added the cross-linker bis(3,5-dibromosalicyl) 
fumarate. The molar ratio of hemoglobin tetramers to cross-
linking reagent was at 1:1.1; the concentration of hemoglobin 
being 0.2 mM. The reaction flask was placed in a water bath 
equilibrated at 37 °C and incubated for 2 hours while purging 
with N2 • The reaction was terminated by placing the reaction 
flask in an ice-bath for 20 minutes. The reaction mixture was 
then dialysed against 0.05 M Tris, 1 mM NaCN, pH 8.5 buffer 
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at 4 °C to remove any unreacted cross-linker (27). 
This cross-linked a99XLHbA was then separated and 
purified from uncross-linked and other side products by ion-
exchange chromatography as done for the purification of 
hemoglobin above. 
3.2.2.2 Cross-linking between Lysine-82,8 1 and Lysine-82,8 2 
(,882XLHbA) 
The ,8-82 lysines of hemoglobin were cross-linked by 
carrying out the reaction with bis(3,5-dibromosalicyl) 
fumarate with hemoglobin in the oxy state. Apart from not 
purging the hemoglobin solution with N2 gas, the experimental 
procedure was similar to the one for a99XLHbA above. While 
incubating, the flask was swirled around slowly every 30 
minutes (23). After 2 hours the contents of the reaction flask 
were chilled in an ice-bath, dialysed against the above 
mentioned Tris buffer and purified by ion-exchange 
chromatography as with hemoglobin. 
3.2.2.3 Sodium Dodecyl Sulphate-Gel Electrophoresis 
Molecular weight analysis of the cross-linked 
hemoglobins, a99XLHbA and ,882XLHbA, was performed by SDS-gel 
electrophoresis. The sample was denatured in SDS treatment 
buffer in a boiling water bath for 10 minutes. The buffer was 
made from 5 ml 0.125 M Tris-HCl pH 6.8, 8 ml 4% SDS, 4 ml 20% 
glycerol, 2 ml 10% mercaptoethanol, and, 1 ml 0.5% bromophenol 
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blue. The denatured sample was loaded onto a SDS homogenous 
12.5% polyacrylamide gel and the separation was carried out 
on a PRAST-System. The gel was stained with Coomassie blue and 
and analysed by a UV-gel scanner. 
3.2.3 crystallization of cross-Linked Hemoglobin 
3.2.3.1 crystallization of a99XLHbA 
Crystals of a99XLHbA were grown out of the high salt 
concentration method of Perutz (40) for human deoxyhemoglobin. 
The cross-linked hemoglobin is dialysed against 0.01 M 
ammonium phosphate buffer of pH 7. o. This is made by the 
addition of 8. 5 ml of 2 M (NH4 ) 2HPO4 plus 1. 5 ml of 2 M NH4H2PO4 
to 2 1 of water. Crystallization was carried out at room 
temperature at a series of buffer concentrations which pass 
through the critical point where crystallization begins. The 
optimum pH, buffer and hemoglobin concentrations are as in 
Table 2. 
Solution c, pH= 6.5, was made by mixing 
0. 8 volumes of 4 M (NHJ 2SO4 plus 
0. 05 volumes of 2 M (NHJ H2PO4 plus 
0 .15 volumes of 2 M (NH4 ) 2HPO4 
to give a total buffer molarity of 3.6. 
Cross-linked hemoglobin was at 6% (60 mg/ml a99XLHbA) to 
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give a final concentration of 1% in the crystallization setup. 
Sodium dithionite was 1.25 M (5.44g in 25 ml water made-under 
N2) • 
The mixing of all solutions above was carried out in a 
glove bag filled with nitrogen gas. Crystallization setup was 
by the batch method. The vials with the above crystallization 
solutions were stored in nitrogen-filled dessicator jars 
sealed with ground and greased glass lids. The crystals took 
over two weeks to grow to an approximate size of 0.7 mm on a 
side. Crystals were obtained in each vial listed in Table 3.1. 
3.2.3.2 crystallization of ,882XLHbA 
The batch method proposed by Ward et al. (59) and Arnone 
et al. (60) for deoxyhemoglobin was used to grow crystals 
,882XLHbA. crystallization setups were from solutions that were 
1% {l0mg/ml) in cross-linked hemoglobin, 10 mM potassium 
phosphate pH 7. o, 100 mM potassium chloride, 4mM sodium 
dithionite, and over a range of 10 to 10.5% PEG-6000. The 
actual volumes of the different solutions that were mixed are 
given in Table 3. 
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Table 2. Crystallization setup for a99XLHbA 
Vial 
1 
2 
3 
4 
5 
6 
7 
698 37 
675 60 
653 82 
623 112 
600 135 
578 157 
563 172 
µl Sodium dithionite µl a99XLHbA 
15 150 
15 150 
15 150 
15 150 
15 150 
15 150 
15 150 
Table 3. Crystallization setup for ~82XLHbA 
Vial 
1 
2 
3 
4 
5 
6 
µl KCl 
100 
100 
100 
100 
100 
100 
µl Sodium µl PEG-
dithionite 6000 
5 
5 
5 
5 
5 
5 
380 
390 
400 
410 
420 
430 
µl XLHb 
200 
200 
200 
200 
200 
200 
42 
315 
305 
295 
285 
275 
265 
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Stock solutions of the above were prepared from which the 
aliquots of the right volumes were pipetted into the vials. 
The original concentrations of the solutions were: 5% (50 
mg/ml) P82XLHbA, 1 M KCl, 1.25 M sodium dithionite, 25% w/v 
PEG-6000. All mixing was done in a glove bag filled with N2 
gas. The vials were stored in sealed glass dessicators under 
nitrogen. Diffraction grade crystals took over four weeks to 
grow, and only appeared in vial 4. 
3.2.4 X-ray Diffraction 
3.2.4.1 crystal Mounting 
Crystals were mounted in thin-walled quartz capillary 
tubes of 0.7 mm bore size as described by King (61). A crystal 
and a small volume of mother liquor was drawn into a Pasteur 
pipette and then pipetted directly into the capillary tube. 
The mother liquor was removed by drawing it away using a 
syringe. A small quantity of mother liquor was left remaining 
in the capillary but away from the crystal. This was done to 
keep the crystal moist. The ends of the capillary were then 
sealed with high vacuum sealing wax and coated with epoxy 
resin. Since the crystals were grown in a deoxy environment, 
the whole crystal mounting process was carried out in a glove 
bag filled with N2 gas. The crystal was mounted on a 
goniometer head with modeling clay. 
3.2.4.2 Data Collection for a99XLHbA 
Diffraction data were collected for a99XLHbA synthesized 
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in the laboratory and for the a99XLHbA sample by provided 
Baxter Blood Substitutes. 
X-ray data for a99XLHbA synthesized our the laboratory 
was collected at the Multiwire Area Detector Facility of the 
Argonne National Laboratory, Argonne, IL. 
Diffraction data for the Baxter-a99XLHbA crystals were 
collected at the R-AXIS II image plate detector facility of 
Abbott Laboratories, Abbott Park, IL. Copper Ka X-radiation 
were produced by a Rigaku RU-200 (12kW) Rotating Anode X-ray 
generator. The overall detector configuration is given in 
Tables 4 and 5. 
Data aquisition is as a series of frames or electronic 
images, each comprising a small oscillation. The individual 
frames are contiguous in that the start of each small 
oscillation range coincides with the end of the previous 
range, and each reflection is expected to appear in several 
adjacent frames. The intensity of a spot is then determined 
as the background-corrected sum of the counts over the frames 
in which it is passing (62). 
Since the automatic indexing algorithm of the R-axis II 
data-processing program used did not require the conventional 
orienting of the crystal before data collection began, the 
crystal was simply centered in the beam and diffraction data 
collection was started. 
Two data sets were collected from the same crystal in 
different orientations and were named a99XLHb and a99XLHb2. 
Table 4. Detector configuration for a99XLHb 
Crystal Name 
Axis 
Starting cp value 
Increment 
Number of Frames 
Spindle axis 
X-ray axis 
Nominal Crystal to 
Detector distance 
Detector 20 angle 
a99XLHb 
0.00 
2.00 
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* +a 
-b 
ao.o mm 
0.00 
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Table 5. Detector configuration for a99XLHb2 
Crystal Name a99XLHb2 
Starting ct, value o.oo 
Increment 2.00 
Number of Frames 48 
Spindle axis * +a 
X-ray axis +c 
Nominal Crystal to 
detector distance 80.0 mm 
Detector 20 angle 0.00 
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3.2.4.2.1 X-ray Data Analysis for a99XLHbA 
Data processing and reduction was done using the R-axis 
II processing program. The steps involved in data reduction 
were: 
1. Determining the centroids ( in detector coordinates and 
scanning angle} of a group of bright spots appearing in the 
images contained in the data set. 
2. Indexing the reference reflections and obtaining an initial 
estimate of the crystal's orientation from a sequence of 
'stills' taken at the start of the data collection process. 
3. Refining the crystal and detector parameters. 
4. Assembling a list of measured reflections. 
5. Computing integrated intensities and standard deviations 
for the reflections assembled in step 4. 
6. Merging together data from the different frames. 
7. Determination of scaling functions to reduce systematic 
error in the assembled data. 
8. Elimination of outliers from the assembled data. 
9. Computation of the scaled merged mean intensities for the 
unique reflections in the data. 
Results from the data analysis and reduction are 
summarised in Table 6. 
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Table 6. Data reduction statistics for a99XLHBA 
Crystal Name = a99XLHb 
Reflection range = 44.13 to 1.81 A 
Limits on h,k,l: = (-31, o, OJ to [ 31, 45, 29J 
I/sig(I) at 1.81 A = 3.00 
Total # of reflections 
observed = 37244 
Number of theoretical 
reflections = 51296 
Percentage of reflections 
recorded = 72.6 
- * -
Crystal Name = a99XLHb2 
Reflection range = 44.17 to 1.80 A 
Limits on h,k,l = (-29, o, OJ to (29, 32, 46J 
I/sig(I) at 1.81 A = 3.00 
Total # of reflections 
observed = 41063 
Number of theoretical 
reflections = 51131 
Percentage of reflections 
recorded = 80.3 
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J.2.4.3 Data Collection for ~82XLHbA 
3.2.4.3.1 Precession Photography 
Diffraction data by precession photography (63) for the 
~82XLHbA derivative were collected on an Enraf Nonius 
Diffractis Generator. The generator was operated at 35,000 VDC 
and 15 mA. Reflections from both zero-level and first-level 
reciprocal lattice planes were recorded, separately, on Kodak 
direct exposure X-ray film using a Type Y 925 Integrating 
Precession Camera. The precession angle for both levels was 
10°. 
Recording of the zero-level was done by orienting the 
crystal, by a series of 'still' and unscreened 3° precession 
photographs, with one of the reciprocal axes parallel to the 
incident X-ray beam. This resulted in set of reciprocal 
lattice planes normal to the beam manifested as a photograph 
of perfectly concentric circles traced out by reflections of 
planes making up the lattice planes. The set of lattice planes 
was then inclined through the chosen precession angle,µ, of 
10° to the incident beam. To prevent upper levels from 
reaching the film an annular screen was inserted between the 
crystal and the film. The position of the screen, s 0 , is given 
by, 
s 0 = rs cotµ 
where rs is the mean radius of the annulus. 
For the zero-level picture taken, rs= 9.7 mm; and s 0 = 
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55 mm, and radius of annulus, to = 2mm. Crystal to film 
distance was 100 mm. The exposures lasted 30 hours. 
Two zero-level pictures were taken for the same crystal, 
90° from each other. The first was taken with the spindle at 
95° 30 1 and the second at 5° 30 1 • 
No upper-level picture was taken due to deterioration of 
the crystal and therefore space group determination was done 
by auto-indexing during Intensity Data collection. The P2 1 
space group was consistent with the precession photographs. 
3.2.4.3.2 Intensity Data Collection for fi82XLHbA 
Data collection for the fi82XLHbA crystal was done at the 
R-AXIS II area detector facility of the Abbott Laboratories, 
Abbott Park, IL. Data collection statistics are as in Table 
7. X-rays were Cu Ka radiation of wavelength 1.5418 A. 
3.2.4.3.3 X-ray Data Reduction for fi82XLHbA 
Data analysis and reduction was done as for the a99XLHbA 
crystal discussed above. The auto-indexing parameters are 
summed up in Table 8. 
Table 7. Detector configuration for ~82XLHbA 
Axis 
Starting Phi value 
Increment 
Number of Frames 
Mounted axis 
Axis parallel to beam 
Crystal to detector 
distance (cm) 
Detector 20 angle 
= 
= 
= 
= 
= 
= 
= 
= 
<I> 
0.000 
3.000 
30 
* +c 
* +a 
8.00 
0.00 
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Table 8. Data reduction statistics for ~82XLHbA 
Resolution range = 53.20 A to 2.00 A 
Number of reflections 
merging Bijvoets = 53187 
Ave. I/sig(I) at 2.00 A = 2.02 
Ave. I/sig(I) at 2.20 A = 2.60 
Cumulative number of 
observed reflections * = 42577 
cumulative number of 
theoretical reflections * = 58219 
Percentage of reflections 
recorded * = 73.1 
* At 2.20 A. 
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3.2.S Calculation of Phases 
3.2.5.1 Difference Fourier Calculation for a99XLHbA 
The two sets of diffraction data were merged and scaled 
using the program PROTEIN (50). The R-merge for the two sets 
of data, a99XLHb and a99XLHb2, was 7.2% (68000 measurements) 
with a total of 44245 unique reflection data (total of 78304 
from 2 sources). R-merge measures the difference in two or 
more data sets that are being merged. These data sets may be 
from a single crystals or different crystals of the same 
molecule. Phases for this a99XLHbA data set were calculated 
using the program PHASES (55) as described below. 
The association of a small molecule with a protein of 
known three-dimensional structure can be studied by means of 
difference Fourier syntheses. This is most conveniently 
possible when the addition of a small molecule to the protein 
results in no change to the space group and only the slightest 
{< 0.5%) changes to the unit cell constants of the native 
protein crystal. This small molecule will, however, give rise 
to a change in structure factor amplitudes of the derivatised 
protein. The Fourier synthesis for the native protein is given 
by 
Pp = 1. L FP expi aP exp-2rrih•x 
V h 
and that for the protein plus cross-linker by 
PpxL = 1. L FPXL expi aPxL exp-27Th•x 
V h 
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since FxL is small, aPXL will not be very different from aP so 
that PpxL may be approximated by 
PpxL ~ .1 L FPXL expi aP exp-2nh•x 
V h 
Here Pp and p~L are the electron densities of the native and 
cross-linked protein, FP and FPXL their structure factor 
amplitudes, and aP and aPXL their phases, respectively. 
The difference in electron density between the protein 
plus cross-linker and the native protein, which corresponds 
to the electron density of the cross-linker, is then given by 
PpxL - Pp ~ .1 L (FPxL - Fp) expi aP exp-21rih•X 
V h 
Structure factors, F for native hemoglobin were calc' 
calculated using the program PHASES (55). Native hemoglobin 
coordinates were from a 1.74 A refinement of deoxy hemoglobin 
(46) obtained from the Protein Data Bank (PDB) of the 
Brookhaven National Laboratory, Uptown, NY (entry = 2HHB). The 
subroutine PDB CDS converted the PDB coordinates to PHASES 
format. The original data set had reflections ranging from -
hmax < h < hmax, o < k < kmax, o < 1 < lmax. These were re-
indexed to O < h < hmax, O < k < kmax, -lmax < 1 < lmax using 
the relation Fhkl = F -hk-L for space group P2 1 ( 64) . The program 
PHASIT calculated Fcalc values for each hkl between 20.0 to 1.8 
!. Difference electron density maps of the type F 0 - Fcalc and 
2F
0 
- Fcalc were calculated using the subroutine FSFOUR. These 
maps were then viewed using the program CHAIN (56). 
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3.2.5.2 Molecular Replacement Method for ~82XLHbA 
Phases for the ,B82XLHbA derivative were calculated by the 
molecular replacement method (65). 
For two identical molecules differing only in orientation 
and position, it is possible to define a general operation 
involving only rotation and translation that will bring the 
equivalent points of electron density in each molecule into 
coincidence. By defining the equivalent points on the two 
molecules by the position vectors X1 and x2 referred to a 
common orthogonal coordinate system, 
X1 = [C]X2 + t 
where [C] is a rotation matrix and t a vector defining 
translation. 
The method is a three-stage process (66): 
1. Determination of the relative orientation, [C], of the 
molecules in the crystallographic asymmetric unit. 
The relative orientations of the molecules in the 
asymmetric unit are determined by comparing the self Patterson 
function of a model protein of known structure, the search 
molecule, with those of the molecule of unknown structure. The 
Patterson functions for the search model, P2 , were computed by 
squaring the calculated structure factor amplitudes (Fcalc) and 
adding a center of symmetry. Patterson functions, P1 , for the 
'unknown' molecule were computed by squaring the observed 
amplitudes (F0 ) and adding a center of symmetry. The phase is 
set to zero. This results in a map showing the vectors between 
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atoms in the unit cell instead of the absolute positions of 
these atoms. The criterion for the correspondence of these 
self-vector sets is by maximizing the product function R (67) 
where, 
R = fuP2 (X2)P1 (X1)dX1 
for the Patterson function P1 and the rotated Patterson 
function P2 (by the rotation matrix [C]) within the volume U 
of the asymmetric unit. R, the rotation function will have a 
maximum value when the two self-vector sets are equivalently 
oriented. The computations for Rare done in reciprocal space. 
Only self-vector sets lying within the largest 
intramolecular distance, r, from the origin of the Patterson 
function are considered. This is done to distinguish them from 
the intermolecular vectors that make up the cross-vector set. 
Choosing r to be a value shorter than the shortest cell 
dimension, the self-Patterson functions are compared within 
a sphere of the radius, r. 
2. From the information in step 1. above, the position t, of 
local non-crystallographic operators is determined relative 
to the crystallographic symmetry elements. 
This translation vector, t, is investigated by 
considering the cross-Patterson vectors that run between 
molecules. When there are two molecules in the asymmetric unit 
which are related by, say a two-fold axis, the two cross-
vector sets related by Patterson center of symmetry can be 
brought into coincidence by rotating the Patterson function 
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around the axis through the origin by 180° and then carrying 
out a translation search. This search is carried out by 
defining a translation function (68), T, such as to maximize 
T(t) = fvP2 (X2,t)P1 (X1)dV 
where tis the translation vector and relates the centers of 
the two molecules. Like the rotation function, the translation 
function depends critically on the choice of radius of the 
vector sets and is carried out on the Patterson modified to 
remove the self-vector set, i.e. 1tl<2r. 
3. Phase determination from the knowledge of the non-
crystallographic operators derived in 1. and 2. 
Once the orientation and position of the 'unknown' 
molecule has been determined by a search molecule, an initial 
set of phases can be calculated. This is done by applying the 
Fourier transform with the coordinates of the now properly 
positioned search model. These phases are then used to compute 
an electron density map to which is fitted the amino acid 
sequence of the molecule. This atomic model is then refined 
against observed diffraction data. 
3.2.s.2.1 Molecular Replacement using MERLOT (51) 
The orientation and position of ~82XLHbA with respect to 
the model structure was determined using the MERLOT package 
of programs (51). The search model was human deoxy hemoglobin 
A tetramer coordinates from the Protein Data Bank, entry= 
2HHB, (46). The setup for the calculation was as follows: 
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1. PROREF: Reflection data for ~82XLHbA were processed and 
expanded by PROREF. A 2.70 A resolution cutoff was applied. 
2. HARMCO: Spherical harmonic coefficients are calculated and 
the data is expanded in terms of spherical Bessel functions 
to generate symmetry equivalent reflections related by 
rotational symmetry about the Z axis. Calculations were 
performed between the resolution limits 8.00 and 5.00 A using 
data over three times the standard deviation and a radius of 
integration of 29.9 A. This is the Patterson cuttoff radius 
and is the highest that can be used for the high resolution 
limit of 5.00 A and is calculated from, 
2.0 * 1T * ARAD 
---------~ 37.6785 
RESMAX 
where ARAD is the maximum Patterson cutoff radius and RESMAX 
the maximum resolution of data chosen for HARMCO. 
3. CROSUM: Calculates the Crowther self rotation function 
(68). The rotation space was sampled in terms of spherical 
polar angles using the output from HARMCO. The spherical polar 
angles I, wand Kare such that angles t and w describe the 
orientation of a rotation axis; angle K is the rotation about 
that axis, Figure 6. However, the results from CROSUM need to 
be converted from~, w, K to 90-~, w, K to be consistent with 
Tanaka's definitions of the angles (69). Angles wand I were 
examined in 37 steps of 5 degrees starting from zero to cover 
all 180° of space. 
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Figure 6. The rotation angle~ which specifies the rotation 
about the axis whose orientation is defined by the polar 
coordinate variables¢ and~-
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4. MAPOUT: Converts the polar angle rotation function from 
above to a polar angle map. 
5. PROCOR: The subroutine PROCOR was used to process the 
coordinates of the model for use in subsequent programs. The 
crystal cell information, like unit cell constants however, 
is that for the unknown, ~82XLHbA. This is done because once 
the orientation of the unknown is determined, the translations 
that need to be applied to position the unknown are done in 
fractions of the unit cell lengths of the unknown. Structure 
factors are calculated using these processed coordinates using 
the subroutine STRFAC. These are calculated for an artificial 
orthogonal unit cell 150 A on the side of space group Pl. 
6. CROSUM: Calculates the Crowther rotation function in terms 
of Euler angles, alpha, beta and gamma, Figure 7. The cross-
rotation function in examined using this routine over the 
asymmetric unit of rotation space. Here the unknown molecule 
is kept stationary while the model is rotated and the rotation 
function is evaluated at various orientations of the model. 
Angles alpha and gamma were evaluated over all Eulerian space, 
i.e. Oto 360°, while angle beta was examined from zero in 37 
steps of five degrees to cover 180° of space. 
7. ROTSYM: calculates the rotation, in spherical coordinates, 
between pairs of orientations, in Euler angles, obtained from 
the cross-rotation function. This allows for determination of 
symmetry relationships between pairs of peaks which can be 
correlated to information on non-crystallographic symmetry 
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Figure 7. Eulerian angles 01 , 02 , 03 relating the rotated axes 
I I I 
X1 , X2 , X3 to the original unrotated orthogonal axes X1, X2 , 
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obtained from the self-rotation function. Here the Euler peaks 
were examined for pairs related by a two-fold rotation and the 
corresponding spherical angles obtained were compared with 
those obtained from the self-rotation function. Only those 
pairs of Euler angles that were 180° away in~ as suggested 
by the results from the self rotation function were considered 
likely solutions to the cross rotation function. 
The Crowther rotation was carried out over a finer grid 
once approximate values had been obtained for alpha, beta and 
gamma. 
These Euler angles were further sharpened by the Lattman 
rotation function (70) using the LATSUM subroutine. 
8. TRNSUM: Calculates the translation function for the model 
(71,72) from the input rotation function angles. The 
translation vectors TA, TB and TC represent the vector from 
molecule 2 to molecule 1 in the asymmetric unit. The 
translation maps were oriented so that they were normal to the 
b-axis of the unit cell. FA, FB and FC are the molecular 
translations that are being solved for. For space group P2 1 
with two molecules in the asymmetric unit the molecular 
translations for all four molecules in the unit cell are: 
Molecule 1 
Molecule 2 
Molecule 3 
Molecule 4 
FAl FBl 
FA2 FB2 
-FAl l/2+FB1 
-FA2 1/2+FB2 
FCl 
FC2 
-FCl 
-FC2 
The intermolecular translation vectors due to all four 
molecules in the unit cell are: 
Vector 
Moll - Mol2 
Mol3 - Moll 
Mol4 - Mol2 
TA 
FA1-FA2 
2FA1 
2FA2 
TB 
FB1-FB2 
1/2 
1/2 
TC 
FC1-FC2 
2FC1 
2FC2 
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The molecule pairs Moll and Mol3 and Mol2 and Mol4 are 
related by crystal symmetry. Therefore, the Patterson vectors 
between them fall along the planes y ± 1/2, which are known 
as Harker sections (73). Translation maps searching for 
intermolecular vectors between these pairs of molecules need 
only be calculated for they= 1/2 sections. However, when 
searching for the vectors between Moll and Mol2 in the same 
asymmetric unit, and not related by the same space group 
symmetry, an entire map in all directions needs to be 
calculated. 
9. RMINIM: This program (74) refines the rotational and 
translational parameters obtained above by varying them till 
a local minimum in found in the R value. Each independent 
parameter is varied in each cycle of minimization in small 
increments about its initial value, and an R value is 
calculated at each parameter value. Angle increments of 0.5 
d~grees and translation increments of 0.005 fractional 
tra,slations (about 0.5 A :or the cell of ~82XLHbA) were used. 
10. ROTTRN: The mode~ ~s rotated and translated twice (since 
66 
there are two solutions, one each for the two molecules in the 
asymmetric unit) to yield the positions of the unknown 
molecule ~82XLHbA. 
3.2.s.2.2 Molecular Replacement using X-PLOR 
1. Calculation of the Rotation Function: X-PLOR uses the real-
space Patterson search method (75-77) to orient the search 
model. Two Patterson maps were calculated. The stationary map 
P2 was calculated from the observed intensities of the 
'unknown' molecule ~82XLHbA by fast Fourier transformation on 
a grid that was 1/4th the high resolution of intensity data. 
The symmetry of map P2 is the Patterson symmetry of the space 
group. The Patterson map Pl was calculated from the observed 
intensities for the self-rotation search. The Patterson 
vectors were rotated using spherical polar coordinates,~, ¢, 
ic that described a two-fold axis relating the two molecules 
in the asymmetric unit of ~82XLHbA. The search routine is 
summarised below: 
Resolution range 
Intensity cutoff 
Method 
Grid 
~min=0.0° 
¢min=0.0° 
icmin=175.0° 
t.=2.5° 
5.o to 3.o A 
4.0 * sigma 
FFT 
0.25 
~max=180.0° 
¢max=180.0° 
icmax=185.0° 
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For the cross-rotation search, Pl, of Patterson symmetry 
"1", was computed from the search model deoxy hemoglobin A 
(46). The Patterson vectors were rotated using Eulerian angles 
(66). Values for the different input variables are shown 
below. 
Resolution range 
Intensity cutoff 
Maximum length of vector 
Size of Pl unit cell(A) 
€ 
8.o to 5.o A 
3.5 * sigma 
66. A 
100.0 * 130.0 * 150.0 
0.25 
All sampled grid points of the computed rotation 
function, RF, were sorted with respect to their product 
correlation value, and a peak search was carried out by a 
matrix metric that is defined as (78) 
1 2 , [ 1 2 ] 1/2 
m(n ,n) = mins=1,ns ~i=1,3~j=1,3(n ij -osn ij)2 
where n 5 is the number of symmetry operators of the space 
group of the crystal and 05 is the rotational part of symmetry 
operators. n1 and n2 are any two rotation matrices. Two RF 
grid points are considered as being in the same cluster if the 
corresponding rotation matrices yield m(n1,nI; < €. Thus, for 
€ = 0.25, matrices belong to the same cluster if they can be 
transformed by a rotation of 10° or less around a certain 
axis. The highest grid point of this cluster is retained while 
the others are discarded. This was repeated for other clusters 
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and the subsequent set of RF grid points are examined by 
Patterson Correlation, PC, refinements. 
2. Patterson Correlation Refinement: The highest peaks of the 
rotation function were subjected to PC-refinement (78). PC-
refinement of the overall orientation (n) of the molecule is 
defined as 
Etotal (O) = (1 - PC(O)) 
where 
PC(O) = 
[ ] 
1/2 
<IE I 4 _ <IE I 2>2>< IE (n) I 4 _ <IE (n) I 2>2> I obs I I obs I I m I I m I 
The angle brackets imply averaging over the set of 
observed reflections expanded to Pl. Eobs denotes the 
normalized structure factors, and Em(n) denotes normalized 
structure factors of the search model placed in a triclinic 
unit cell identical in geometry to that of the crystal. 
Using reflections between 8.0 A and 4.5 A that were 3.5 
times over sigma, the search model was then oriented and PC-
refined at each position as determined by the rotation 
function above. The PC-refinement procedure consisted of 15 
steps of conjugate gradient minimization of Etotal for the 
overall orientation n of the search model. 
3. Calculation of the Translation Function: Translation 
searches of the rotated search model was carried out using the 
X-PLOR protocol. Since there are two molecules in asymmetric 
unit of the ~82XLHbA crystal, three translation searches were 
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carried out. In the space group P2 1 with b axis unique, they 
component of the geometric center of the search model is 
arbitrary when searching with a single copy of the molecule. 
It is therefore necessary to first determine only the relative 
x and z coordinates by a two-dimensional summation. Once the 
x and z positions of both molecules in the asymmetric unit 
have been determined, a third search is carried out to 
determine the relative y positions for the two molecules. 
The first search was in the x and z directions to 
position the first molecule A. This search was performed in 
a two dimensional grid of 34 Ax 52 A, which are roughly half 
the dimensions of the a and c axes of the unit cell (79). This 
grid spanned the asymmetric unit of the unit cell of ~82XLHbA 
Reflections used were limited to those above 3.5 times sigma 
and between the resolution limits 10.0 - 4.5 A. 
The second search was done to position the second 
molecule, B, in the asymmetric unit. Prior to this translation 
search, the first molecule A was rotated about the two-fold 
axis~ at~= 90.0° and 0 = 0.0° that relates the orientations 
of the two molecules A and Bin the asymmetric unit. This was 
according to the results from the self-rotation search carried 
out in step 1. above. Once properly oriented, a search was 
carried in the x and z directions to position B in the 
asymmetric unit. 
Translation searches were carried out for a third time 
to determine the relative y translation between the two 
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molecules A and Bin the asymmetric unit. The first molecule 
was held fixed at xA, y = o, zA. They position of the second 
molecule was then varied. Since the x and z positions of the 
two molecules are known up to a 0.5 translation, four 
translation functions had to be carried out. Translations were 
limited to a 1-dimensional grid of length 96 A, roughly the 
length of the b edge of the unit cell. The four translations 
were carried out with, 
1. translation vector = 0.0 o.o 0.0 
2. translation vector = 0.5 o.o 0.0 
3. translation vector = 0.5 o.o 0.5 
4. translation vector = o.o o.o 0.5. 
3.2.6 Phase Refinement 
3.2.6.1 a99XLHbA: Refinement using TNT (54) 
Refinement of the a99XLHbA structure was carried out by 
the gradient methods as incorporated in the TNT package of 
programs. The refinement strategy involved the following 
steps: 
1. Conversion of the input reflection data file to a format 
acceptable to TNT. The CORRECT routine resorted the data file 
containing the hkl indices, their F0 values and the 
corresponding sigma values for each F O value. The routine also 
generates the corresponding Friedel pairs for each reflection 
by assuming that each Friedel' s law of Ihkl = I-h-k-t holds. Ihkt 
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and I_~~l are the intensities of the corresponding hkl and 
-h-k-1 reflections. 
2. The native deoxy HbA PDB coordinate set, entry 2HHB (46), 
was then subjected to least-squares refinement restrained 
against the observed reflection data. This was carried out in 
two major stages. In the first stage, the B-factors {thermal 
parameters) were set to an overall value for all the atoms. 
This value for Boverall was determined by the RFACTOR subroutine 
in TNT. The positional parameters, XYZ, were then refined with 
this value for Boverall kept constant. Refinement was then 
carried out on Boverall and XYZ in alternating cycles. This was 
done until the residual index, R, improved to 24.0 %. The R-
value is a guide to the correctness of fit between the 
calculated structure factors, F calc 1 and the observed 
reflection amplitudes, F0 , and is defined by the relation, 
R = 
The next step involved refinement of individual B factors 
for the atoms and the positional parameters in successive 
steps until the R-value was down to 21.0 %. At this stage, 
difference electron density maps were calculated with the 
refined coordinate set from above and the observed data set. 
The F -F l and 2 *F -F l maps calculated by the program PHASES o cac o cac 
(55) were viewed graphically. The refined model was fitted to 
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areas of difference density indicating movement of residues 
and water molecules associated with the protein. Also, a 
stretch of density, 3*a, was observed in the F 0 -Fcalc map 
between the NZ of the two Lysines-a99. The cross-linker was 
fitted to this density. The cross-linker spanned the atoms: 
Ol-Cl-C2-C3-C4-02 
with Cl bonded to the NZ of one Lysine-a99 and C4 bonded to 
the NZ of the other Lysine-a99 as in Figure l.l(a). 
3. The third phase in the refinement strategy involved 
refining both, the individual B-factors, and the positional 
parameters, XYZ, simultaneously. This was accompanied by 
regular analysis of the difference electron density maps and 
manual re-fitting of the residues and the cross-linker to the 
electron density. When the R-factor ceased to decrease from 
a value of 17.6 % and little or no density was observed in the 
F O - F calc map refinement was stopped. 
3.2.6.2 ~82XLHbA: Refinement using X-PLOR 
3.2.6.2.1 Rigid-Body Refinement 
The correctly oriented and positioned molecules of 
~82XLHbA were subjected to rigid-body refinement using X-PLOR. 
The protein was divided into several groups and minimized as: 
(1) the two molecules in the asymmetric unit as one rigid 
body, 
(2) the two molecules in the asymmetric unit as separate 
rigid groups, 
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(3) each of the four chains was treated as a separate rigid 
body. 
The positions of these rigid groups of atoms were refined 
against the observed diffraction amplitudes. Refinement was 
done in stages starting with low resolution reflections. 
Reflections at higher resolution were added gradually as the 
refinement progressed. The stages were: 
Resolution range (A> n * Sigma 
15.0 - 4.50 4 
15.0 
-
3.50 4 
15.0 - 3.00 4 
15.0 - 2. 70 4 
15.0 - 2.50 4 
15.0 - 2 .30 4 
15.0 - 2.25 4 
15.0 - 2.23 4 
10.0 - 2.23 3 
10.0 - 2.23 2 
3.2.6.2.2 Powell Minimization: 
The conjugate gradient method (80) as incorporated in X-
PLOR was used to refine the structure of the positioned search 
molecule against diffraction data. No atoms were constrained 
during the refinement process. Several batches of 60 cycles 
each of refinement were carried out with each directed at 
minimizing the target (81) 
where Echem comprises 
bonding geometry, 
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E = Echem + WEexp 
information about equilibrium covalent 
vibrations, and hydrogen-bonded and 
nonbonded interactions. These quantities were obtained from 
small molecule crystallography and spectroscopy and are part 
of the X-PLOR program package. Eexp describes the difference 
between observed and calculated diffraction data. The weight 
w relates Eexp to Echem· This was determined by using a molecular 
dynamics run with w set to zero, starting with the initial 
structure after rigid-body minimization. The weight w was then 
adjusted to make the magnitude of the gradients of Echem and 
Eexp of the molecular dynamics structure equal. Weight w was 
determined to be around 440,000 kcal/mol. 
After about 300 cycles of conjugate gradient 
minimization, difference maps, Fobs - Fcalc and 2*Fobs - Fcalc' 
were calculated to monitor changes in the structure of the 
partially refined molecule using the graphics program CHAIN 
(56). Water molecules were added to areas of density that were 
not occupied by the backbone and side chains of the molecule. 
Only those areas of density that were within hydrogen-bonding 
distance, 2.0 - 2.5 A, of a donor or acceptor atom on the 
protein were targeted as sites occupied by water molecules. 
At this stage the cross-linker was patched into the 
electron density observed between the two Lysines-,882. The 
topology and parameter files for the patch routine are in 
Appendix 1. The cross-linker was sketched out, Figure 8., and 
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Figure 8. The fumarate cross-linker with four carbon atoms, 
two oxygen atoms, and two hydrogen atoms used to patch into 
the electron density between the Lysines-82P of the two p 
chains. 
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minimized to a minimum energy structure 
InsightII/Discover package of programs (82). 
3.2.6.3.3 Refinement by Simulated Annealing: 
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using the 
Simulated annealing is carried out by simulating 
molecular dynamics on the fi82XLHbA. The dynamics is carried 
out at a 'high temperature'. The annealing is done by slowly 
decreasing the 'temperature' of the system against a 
crystallographic 'target function', which in this case is the 
diffraction data. This target function consists of an 
effective potential energy that comprises the stereochemistry 
and non-bonded interactions of the macromolecule. 
The setup for the simulated annealing refinement 
procedure is as follows: 
1. Determination of weight w as in the conjugate 
gradient minimization process above. Weight w was determined 
to be 440,000 kcal/mol. 
2. Molecular dynamics for 0.025 ps, T = 1500 K, 10.0 to 
2.23 A, timestep = 0.0005 ps, number of steps: nstep = 50. 
3. Slow-cooling in 48 steps of -25 Keach until the 
temperature reached 300 K. Dynamics at each step for 0.025 ps, 
timestep = 0.0005 ps, nstep = 50. 
4. Minimization by the conjugate gradient algorithm, 
160 steps, w = 440,000 kcal/mol at 300 K. 
4. RESULTS AND DISCUSSION 
4.1 Isolation of Hemoglobin 
Hemoglobin A was purified of the minor hemoglobins and 
of other red cell components by anion exchange chromatography. 
The gel used was Sephadex A-50. The mixture was resolved into 
its components by eluting using a linear gradient buffer 
system whose pH ranged from 8.5 to 7.2. The chromatogram in 
Figure 9 shows the four peaks from the four different 
fractions eluted. HbA2 with the greater positive charge of +4 
elutes before HbA which is the largest peak in the 
chromatogram. The other peaks are due to the other proteins. 
The purity of HbA eluted out was tested by clinical gel 
electrophoresis. 
4.2 Purification of a99XLHbA and ~82XLHbA 
Purified hemoglobin was cross-linked between the Lysines-
99 of two a chains in the deoxy state and purified by anion-
exchange chromatography using Sephadex A-50 as for native 
hemoglobin above. Figure 10 shows the resulting 
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Figure 9. Chromatogram of purification of HbA by anion-
exchange chromatography using Sephadex A-50. The largest peak 
is from HbA. The other peaks are, in order of elution, an 
unknown cytosol protein, HbA2 and HbA1c. 
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Figure 10. Chromatogram of the purification of a99XLHbA by 
anion-exchange chromatography using Sephadex A-50. a99XLHbA 
is the second peak in the chromatogram. The first peak is from 
un-cross-linked HbA, and the third peak is due to side 
products of the cross-linking reaction. 
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chromatogram. The first peak is due to un-cross-linked 
hemoglobin. Since cross-linking between two lysines reduces 
the total positive charge on the protein by two, the cross-
linked species follows the native protein on elution. The 
third peak is probably due to a mixture of cross-linked 
hemoglobins resulting from mis-directed reactions with the 
cross-linker, bis(3,5-dibromosalicyl) fumarate. The a99XLHbA 
sample was then analysed by sodium dodecyl sulfate-gel 
electrophoresis. This analysis, performed under denaturing 
conditions revealed two separate bands, one corresponding to 
the hemoglobin monomer molecular weight of approximately 16 
kDa due to the free (3 chains and the other to the dimer 
molecular weight of approximately 32 kDa due to the two a 
globins linked to each other covalently, Figure 11. These 
bands, studied by a gel scanner were present in equivalent 
amounts. 
A similar purification procedure was carried out with the 
(382XLHbA species, Figure 12. Here too, the sos gel revealed 
two bands of equivalent intensity, one corresponding to the 
hemoglobin monomer, the two free a chains, and the other to 
the dimer, corresponding to the cross-linked (3 globins, Figure 
11. 
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Figure 11. SOS-PAGE ( 12. 5 % acrylamide) for a99XLHbA and 
P82XLHbA with molecular weight standards. Going from left to 
right, P82XLHbA is in the third lane and a99XLHbA is in the 
fifth. In each case two bands, of equal intensity with a gel 
scanner, were observed. One was of the two uncross-linked 
monomers and the other of the cross-linked dimers. The first 
lane was due to standard markers: 
a Lactalbumin (14kDa), Carbonic anhydrase (29kDa), 
Glyceraldehyde-3 Phosphate dehydrogenase (36kDa), Egg Albumin 
(45kDa), and Bovine Albumin (66kDa). 
Lanes 2, 4, 6, 7, and 8 were other cross-linked 
hemoglobin species prepared by other members in the 
laboratory. 
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Figure 12. Chromatogram for the purification of P82XLHbA. Peak 
II is due to pure P82XLHbA. Uncross-linked HbA elutes first 
and is the first peak on the chromatogram. 
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4.3 X-ray Diffraction studies of a99XLHbA and ~82XLHbA 
4.3.1 Data analysis for a99XLHbA 
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Preliminary analysis of the diffraction data resulted in 
a set of values for the unit cell constants for the a99XLHbA 
crystal. These crystals were grown under conditions that were 
identical to those for native deoxy hemoglobin (40). Cell 
constants for data collected at both Argonne National 
Laboratory and Abbott laboratories and are listed in Table 9. 
The unit cell constants, especially the /3 angle, for data 
collected at Abbott Laboratories were closer to those for 
native hemoglobin ( 46), Table 9. This implied that the 
position and quarternary structure of the modified hemoglobin 
was the same as that of native HbA. Any changes due to cross-
link would then be largely local in the area of the 
modification. Consequently only the data collected at Abbott 
Laboratories were used in calculating the structure of 
a99XLHbA. 
4.3.1.1 Results of Difference Fourier Calculations 
The difference electron density, approximately 3.5*a, in 
the region of the cross-linker is shown in Figure 13. The 
density is observed to stretch out to roughly the size and 
shape of the cross-linker. Using the modeling program CHAIN 
(56) the fumaryl cross-linker was positioned into this 
electron density. Amide bonds between the Lys-a99 and the 
cross-linker were formed by only a slight rotation of the 
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lysine side chains, Figure 14. The conformation of the cross-
linker with regard to the rest of the protein is shown in the 
stereographic Figure 15 which is an atomic model of a99XLHbA 
viewed down the molecular dyad. The cross-linker seems to have 
deviated somewhat from planarity. This is due to a slight 
rotation about the carbon-carbon single bond of the fumaryl 
group. 
4. 3. 1. 2 Structural Comparisons between a99XLHbA and Native HbA 
Differences between the cross-linked hemoglobin and 
native HbA were observed to be minimal. This was not 
surprising since the cross-linker was large enough to span the 
distance between the Lys-a99s. Also, the temperature factors, 
B-factors, of the lysines were reported to be relatively high 
(46), indicating they were relatively unrestricted in their 
movements. The cross-linked Lys-a99 atoms had B-factors 
ranging from 26.0 to 40.0 A2 • There were a few movements with 
residues in the vicinity of the cross-linking site, which was 
largely to accomodate the cross-linker. 
Figure 16 has the atomic models of the a99XLHbA and 
native HbA superimposed on each other. Distances measured are 
from the NZ of one Lys-a99 to the only two residues that show 
any significant displacement due to cross-linking and are in 
Table 11. Arg-fil04 seems to have moved further from Lys-a99, 
but Glu-fil0l has moved closer, Figure 17. These residues are 
most closely associated with the Lys-a99 and extend into the 
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Table 9. Cell constants for a99XLHbA and native deoxy HbA 
Abbott Labs. Argonne Natl. Lab. Deoxy HbA 
Space group P2 1 P2 1 P2 1 
a (A) 63.26 63.18 63.15 
b (A) 83.45 83.97 83.59 
C (A) 53.79 53.85 53.80 
/3 (deg) 99.47 99.95 99.34 
Volume (A 3) 2.8*105 2.8*105 2. 8*105 
Subunits per 
Asymmetric unit 1 tetramer 1 tetramer 1 tetramer 
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Figure 13. Stereo drawing of F0 - F~Lc map showing density, 
3*a, due to the cross-linker between the two Lys-a99s. 
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Figure 14. Electron density map for a99XLHbA. The 2F0 -Fcalc map 
is un-averaged and on it is superimposed the atomic model of 
the modified hemoglobin. 
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Figure 15. Stereo drawing of the a99XLHbA atomic model viewed 
down the molecular dyad. The cross-linker is seen to stretch 
from one Lys-a99 to the other. 
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Figure 16. Distances between residues neighboring the Lys-cx99s 
in the central cavity of the molecule. The darker lines are 
of cx99XLHbA and the lighter lines are of native HbA. The 
distances measured are from the N1 of one Lys-cx99 and the two 
closest Glu-filOl and Arg-~104 residues. These are the only two 
residues whose side chains have undergone displacement due the 
cross-link. Table 10 lists the distances in greater detail. 
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Table 10. Distances in A from the Lys-a99 N1s 
a99XLHbA HbA 
a 1a 2 Lys-99N1 5.71 7.47 
a 1a 2 Lys-99Ca 15.60 15.60 
a, Lys-99N1 -
P, Glu-l0lC0 8.17 8.12 
a, Lys-99N1 -
P, Arg-104C1 7.99 8.39 
a, Lys-99N1 -
P2 Glu-l0lC0 8.12 8.31 
a, Lys-99N1 -
P2 Arg-104C1 10.44 10.39 
az Lys-99N1 -
P, Glu-l0lC0 7.84 8.38 
az Lys-99NI" -
P, Arg-C1 7.99 8.39 
az Lys-99N1 -
P2 Glu-101C0 7.36 7.09 
az Lys-99N1 -
P2 Arg-104C1 8.24 7.54 
------------------------------------------------------------
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Figure 17. Superposition of the a99XLHbA and native HbA 
showing the relative displacements of the Lys-a99s, Glu-~lOls 
and Arg-~104s from native HbA. HbA is drawn in the lighter 
lines. 
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Figure 18. Superposition of the a99XLHbA and native HbA 
backbone structures showing the conservation of the overall 
tertiary structure after modification. HbA is sketched in the 
lighter shade. 
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central cavity of hemoglobin. There is also one water molecule 
hydrogen-bonded to the oxygen of the furnaryl cross-linker. 
A superposition of the backbone atoms of cx99XLHbA on 
native HbA, Figure 18, shows no significant differences 
between the native and modified protein backbone structure 
(see Appendix 2 for RMSD diagrams). Even the Ca atoms of the 
Lys-cx99 that are cross-linked are unaffected in their relative 
positions. 
4.3.2 X-ray studies on ~82XLHbA 
4.3.2.1 Precession Photography 
Two zero-level precession photographs were taken 90° from 
each other. Higher level photographs could not be taken on the 
same crystal due to deterioration of the crystal. However, the 
space group which was determined by the auto-indexing program 
during data collection was consistent with the photographs. 
From the zero-level photographs, one of the hkO layer, Figure 
19, and the other of the hOl layer, Figure 20, the reciprocal 
lattice hand k planes were perpendicular to each other. Also, 
the hand the 1 planes were at an acute angle of 78.5°. This 
. * indicated a monoclinic cell with the measured angle fi_- equal 
to 78. 5 ° and therefore ~ was equal to 101. 5 °. This was 
unexpected since the crystal was grown under deoxy conditions 
from PEG-6000 by Ward et al. (59) and Arnone et al. (60), and 
both obtained orthorhombic crystals of space group P2 12121 with 
one tetramer in the asymmetric unit. 
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Figure 19. Zero-level precession photograph of the hkO layer 
of P82XLHbA, µ= 10°, crystal to film distance= 100 mm. 
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Figure 20. Zero-level precession photograph of the hOl layer. 
The crystal is of P82XLHbA, µ = 10°, crystal to film distance 
= 100 mm.· 
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4.3.2.2 X-ray Data Analysis for ~82XLHbA 
The unit cell constants for the crystal were calculated 
from the data collected and analysed as described in section 
3. 2. 4. 3. The crystal was monoclinic and of space group P2 1 
with two tetramers in the asymmetric unit of the crystal, 
Table 11, with a total of four tetramers ~82XLHbA in the unit 
cell. Data extended up to a resolution of 2.22 A. 
4.3.2.3 Molecular Replacement Method using MERLOT (51) 
4.3.2.3.1 The Rotation function 
1. Self Rotation Function: The Crowther rotation function 
revealed a peak at ~=168.5°, w=90° and ~=180° that was 8.5 
times sigma. The symmetry related peak is at correspondingly, 
78.5°, 90°, and 180°, Table 12. There were two smaller peaks 
about 3.2 times sigma on the map. This large peak indicates 
clearly the position of the axis relating the two tetramers 
in the asymmetric unit of ~82XLHbA by a two-fold rotation. 
2. Cross Rotation Function: The cross rotation function was 
carried out using Patterson fubctions calculated from the 
coordinates of native deoxy HbA (46). The rotation of this set 
of calculated Pattersons was done in Euler angles and resulted 
in several sets of Eulerian angles, Table 13. Pairs of these 
sets were then examined by the ROTSYM routine in MERLOT for 
two-fold relationships that matched the ones from the self 
rotation function. This was done by calculating in spherical 
Table 11. Cell Constants for P82XLHbA 
Space group 
a (A) 
b (A) 
C (A) 
p (deg) 
Volume (A 3) 
Molecules per 
asymmetric unit 
P2 1 
65.30 
96.20 
101.1 
101.5 
6.2*105 
2 tetramers 
110 
111 
Table 12. Self Rotation Function 
RF(*sigma) 
1. 78.5 90.0 180.0 8.5 
2. 168.5 90.0 180.0 8.5 
(the peak at¢ is the same as that at 90-¢, in MERLOT) 
112 
Table 13. Cross Rotation Function (Euler angles a,~, ~) 
Peak RF(relative %) 
1. 45.0 80.0 100.0 100.0 
2. 45.0 100.0 80.0 98.6 
3. 157.0 75.0 265.0 79.6 
4. 157.0 105.0 275.0 77.1 
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angles, t, wand~, the distance between two sets of Euler 
angles. Since the search was for two-folds,~ was limited to 
180°± 5. Sets with~ and w values that were close to those 
obtained in the Self Rotation search above were considered 
likely solutions to the rotation problem. Of all the Euler 
angle sets examined only two sets were at the spherical angle 
distance suggested in the self rotation search, Table 14. 
These two sets were then considered to be the orientations of 
the two P82XLHbA molecules in the asymmetric unit. The~ angle 
11.8° is the same as 180°- ~ , 168.2°, of the self rotation 
results (Euler angles marked with* in Table 14). 
4.3.2.3.2 The Translation Function 
With two molecules in the asymmetric unit, the 
positioning of the hemoglobin tetramer model was done by the 
translation function. The peaks from molecule 3 to molecule 
1 and from molecule 4 to molecule 2 of the unit cell are due 
to the vector between orientations related by a two-fold screw 
axis and the peaks are constrained to lie on Harker sections 
(73) . Molecules 1 and 2 would then be the two P82XLHbA 
tetramers in the asymmetric unit related by non-
crystallographic symmetry. Three maps were calculated and the 
results are summarised in Table 15. 
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Table 14. Rotation between peaks 
First Peak Second Peak 
225.0 80.0 100.0 45.0 100.0 80.0 90. 0 14 .1 180. 0 
* 225.0 80.0 100.0 157.0 105.0 275.0 11.8 86.6 178.7 
115 
Table 15. Translation Function results 
Vector TA TB TC 'Iranslation 
F\mction (%) 
Molecule 3 - Molecule 1 
29.00 50.00 3.00 100.0 
Molecule 4 
-
Molecule 2 
43.00 50.00 97.00 100.0 
Molecule 2 
-
Molecule 1 
42.00 72.00 52.00 100.0 
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4.3.2.3.3 R-value refinement 
The rotational and translational parameters obtained 
above were improved using the routine RMINIM (74) as 
incorporated in the MERLOT package (51). The rotational and 
translational parameters were varied stepwise till a local 
minimum in the R-value was obtained. The R-value dropped from 
an initial value of 49% to 47% after 30 cycles of RMINIM 
refinement. The final values for the orientation, in Euler 
angles, and translation, in fractional coordinate coordinates, 
for the positions of the two ,B82XLHbA tetramers in the 
asymmetric unit are summarised in Table 16. The search 
molecule of native deoxy HbA was then positioned at these two 
sites and this molecular replacement solution was subjected 
to crystallographic refinement against the observed 
diffraction amplitudes by the program X-PLOR (52). 
4.3.2.3.4 crystallographic Refinement using X-PLOR 
Coordinates of the two ,B82XLHbA tetramers from the 
molecular replacement solution of MERLOT were subjected to 
crystallographic refinement. The refinement was in two stages 
against the observed diffraction amplitudes, F0~. The first 
stage was by treating the molecules as rigid bodies. The 
second was by the conjugate gradient method of Powell (80). 
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Table 16. Orientation and Translation from RMINIM 
a /3 X y z 
224.72 79.45 98.95 0.1425 0.0020 0.0150 
156.25 106.51 274.25 0.2195 o. 7102 0.4875 
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4.3.2.3.4.1 Rigid-Body Refinement 
Rigid-body refinement of the coordinates from the 
molecular replacement solution was done in stages of 
increasing resolution ranges. Refinement was started with data 
at a maximum resolution of 4.5 A. As refinement progressed 
higher resolution reflections were added gradually added until 
the resolution limit was reached. With the highest resolution 
data of 2.23 A, the R-factor was 38.0 % and stayed constant 
at that value, implying that an energy minimum had been 
reached. 
4.3.2.3.4.2 Conjugate Gradient Minimization 
After 200 cycles of conjugate gradient minimization the 
R-factor was brought down to 3 o. 3 % • Further attempts at 
minimization did not have any effect on either the R-factor 
or the total potential energy of the molecular system. 
4.3.2.4 Molecular Replacement using X-PLOR (52) 
The structure of ~82XLHbA was solved by the real space 
search method (74) as incorporated in X-PLOR. 
4.3.2.4.1 Self Rotation Function 
A truncated list of the top 10 rotation peaks from the 
self rotation search is listed in Table 17. A graphical plot 
of the self rotation function is shown in Figure 21. It is 
obvious from the list of rotation function peaks and the plot 
that besides the peak at the origin the largest peak is at 
w = 90.0, ~ = o.o, and K = 180.0. This large peak indicates 
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Table 17. Self Rotation Function, top ten peaks 
index K, RF-function 
1 0.000 0.000 180.000 14.6991 
293 90.000 0.000 180.000 14.1392 
838 7.500 0.000 180.000 12.9697 
907 90.000 82.500 180.000 12.8995 
943 82.500 0.000 180.000 12.8491 
1192 90.000 7.500 180.000 12.4453 
1239 67.500 87.500 180.000 12.3790 
1245 157.500 90.000 180.000 12.3703 
1433 45.000 90.000 180.000 12.1770 
1662 15.000 0.000 180.000 11. 9964 
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Figure 21. Contour plot showing the self-rotation function of 
data between 8 to 4 A resolution with~ held fixed at 180° 
(spherical polar coordinates). The maximum, marked y, is 
assumed at the crystallographic dyad whereas the non-
crystallographic elements is marked x. 
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the presence of a non-crystallographic two-fold axis relating 
the two molecules in the asymmetric unit of the ,882XLHbA 
crystal. 
4.3.2.4.2 Cross Rotation function 
The cross-rotation function was calculated using the 
refined coordinates of native deoxy HbA (46). The highest 
rotation function peaks were refined by PC-refinement (see 
section 3. 2. 5. 2. 2) . The largest eleven of these peaks are 
listed in Table 18 showing the position of the rotation 
function peaks before and after PC-refinement. In Table 18 the 
first set of three Euler angles are the angles before 
refinement, the next three angles are those after PC-
refinement, and the last column is the correlation coefficient 
of the rotation function. The correlation coefficient of all 
the orientations was filtered by PC-refinement. The collection 
of peaks that survived PC-refinement were plotted graphically 
against their corresponding rotation function peak index and 
is shown in Figure 22. 
From the last set of eleven possible orientations, peaks 
with orientations that were within 10° of each other were 
grouped together into sets. The orientation in each set with 
the largest correlation coefficient was assumed to be the 
orientation of the actual rotation function, as below 
of 
Set# 
I. 
II. 
III. 
IV. 
The highest 
each set, 
Set# 
I 
II 
III 
IV 
of these 
Peak # 
5031 
4 
3994 
103 
Peak #s 
1 & 5031 
4, 736 & 4186 
64, 341 & 3994 
103 & 494. 
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peaks was chosen as representative 
e.1 e.i e.'J. 
246.65 32.74 117. 85 
259.18 31.75 81.79 
236.10 37 .47 306.53 
272.11 33.82 250.85 
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Table 18. Cross-Rotation Function after PC-refinement 
Before After 
# /J 1 /J 2 /J 3 0 1 /J 2 /J 3 Peak# RF 
1. 245.6 32.5 119.6 246.7 32.9 117.7 1 0.18012 
2. 259.6 32.5 79.6 259.2 31.7 81.8 4 0.18165 
3. 237.4 37.5 307.9 236.9 37.4 305.4 64 0.18670 
4. 269.9 32.5 251. 9 272.1 33.8 250.8 103 0.19090 
5. 223.2 40.0 326.1 235.6 37.9 307.0 341 0.14518 
6. 282.6 35.0 232.4 270.8 34.5 251.8 494 0.17881 
7. 276.3 32.5 60.3 257.9 33.9 82.7 736 0.10499 
8. 260.1 37.5 104.4 245.8 32.6 118.1 1105 0.17803 
9. 254.4 37.5 293.5 236.1 37.5 306.5 3994 0.18949 
10. 244.6 25.0 93.6 256.7 31. 8 83.4 4186 0.17585 
11. 240.2 42.5 122.5 246.6 32.7 117.8 5031 0.18267 
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Figure 22. Cross-rotation function peaks after PC-refinement 
Refined PC 
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The ROTMAN facility in X-PLOR was used to measure the 
'distance' or metric between pairs of the four rotation 
matrices listed above. The angles between these different 
orientations are summarized in Table 19. From the angle 
distances it is evident that there are two apparent solutions 
to the rotation problem. One of these is real. Since peaks I 
and III and peaks II and IV are related by two-fold symmetry 
as suggested by the self rotation results, it is possible to 
take any one peak from each of these two sets as the solution 
to the rotation function problem for one of the two molecules 
in the asymmetric unit. The second molecule is generated by 
applying non-crystallographic symmetry to the first i.e. 
generating the second position by rotating the first molecule 
by 180° about the axis suggested by the self rotation 
function. 
Since it was not apparent which of the two sets of peaks, 
the set with peaks I and III or the set with peaks II and IV, 
was the correct solution, translation searches were carried 
out with both these 'solutions'. A unique solution was found 
for the translation function using peak IV that positioned 
each molecule in the asymmetric unit. First the x, z position 
of the two molecules, whose orientations were defined by peaks 
II and IV, were determined independently. The symmetry of the 
space group P2 1 with b axis unique implies that the y 
component of the geometric center of the search model is 
arbitrary when searching with a single copy of the molecule. 
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Table 19. Orientations and positions of the two molecules in 
the asymmetric unit. 
* Molecule x, y,z 
A 
B 
272.11 33.82 250.85 0.100 0.000 0.240 
259.18 31.75 81.79 0.139 0.750 0.580 
* Fractional coordinates of the geometric center of the 
molecule. 
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Figures 23 (a) and (b) show the translation searches with the 
properly oriented search model. For the first molecule A, the 
peak was at xA = 0.100 and zA = 0.240 in fractional 
coordinates. For the second molecule B the peak was at x8 = 
0.139 and z 8 = 0.080. 
Second, the relative position along y of molecules A and 
B was determined by varying the position of molecule B while 
keeping molecule A fixed at xA, y = o, zA. Since the x8, z8 
position of molecule B was determined only up to an additive 
constant 0.5, four translation searches were required. The 
translation search that used x8 + 0.5, z8 + 0.5 produced an 
unambiguous peak at y = 0.750, Figure 23c, in the fourth 
translation search. The final orientations and positions of 
the two molecules before rigid-body refinement are summed up 
in Table 19. 
4.3.2.5 Crystallographic Refinement using X-PLOR 
The final step of the structure-solving process consisted 
of several cycles of refinement by rigid-body and conjugate 
gradient minimization of the correctly positioned molecules 
in the unit cell of the crystal. This was followed refinement 
by one round of simulated annealing. 
4.3.2.5.1 Rigid-Body Refinement: 
By slowly adding higher resolution data the R-factor was 
brought down to 32.0%. Each time, both the positions of the 
two molecules and and of the individual domains involving the 
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Figure 23. Translation searches after PC-refinement for (a) 
molecule A, (b) molecule Band (c) molecule B while A is held 
fixed at its correct position. 
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four chains on each tetramer were refined. 
4.3.2.5.2 Powell Minimization 
After three cycles of conjugate gradient minimization, 
the R-factor dropped to 27. 3 !1,-0 • At this stage difference 
electron density maps were calculated using calculated 
structure factors, F from the refined coordinates of the calc' 
properly positioned search molecule and the observed 
amplitudes of the diffracted X-rays, Fobs" Difference maps of 
the type Fobs - Fcalc and 2*Fobs - Fcalc were calculated. The 
program CHAIN (54) running on a Silicon Graphics workstation 
was used to view the density maps. The difference density 
observed was attributed mainly to positions of water molecules 
present in the crystals of fi82XLHbA. Most of these difference 
density peaks were within hydrogen bonding distance of a donor 
or acceptor atom on fi82XLHbA. It was also noticed that the 
lysines-fi82 had moved closer to each other. In deoxy Hb A the 
N€'s of the two lysines-fi82 are 9.33 A apart (46). These N€'s 
had moved to within 5. 7 A of each other after the above 
refinement procedures. The cross-linker, bis(3,5-
dibromosalicyl) fumarate, spans roughly 3.80 A if measured 
between the two carbonyl carbon atoms that form the amide bond 
with the lysine N.,.s, Figure 8. However, at this stage the 
difference density between the two lysines-fi82 was barely 
perceptible. 
To improve the calculated phases, water molecules were 
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added to the model in the areas that showed difference density 
that was, 
(1). above 2.5a of the mean difference density. 
( 2) • 
nitrogen, 
molecule. 
between 2.5 to 3.5 A from a donor atom, like 
or acceptor atom, like oxygen, on the ,882XLHbA 
Water molecules were first added in batches of 30. All 
additions of water molecules was done manually. After each 
addition of a batch of water molecules the ,882XLHbA molecular 
system was subjected to a short cycle of Powell minimization 
and difference maps were recalculated. A fresh batch of water 
molecules was added to difference density peaks, and the 
process of refinement, difference map calculation and addition 
of water molecules was continued till there was no significant 
change in the R-factor and no large difference peaks were 
observed. A total of 374 water molecules were added to the two 
,882XLHbA molecules in the asymmetric unit. At this stage the 
R-factor of the molecule was 24. 5 % • The only observable 
difference density, 3*a, now was between the Nrs of the two 
lysines-82. This was due to the cross-linker molecule. The 
cross-linker was built into this region of difference density 
and merged into the coordinate file of the ,882XLHbA molecules 
using the PATCH routine in X-PLOR. 
4.3.2.5.3 Refinement by Simulated Annealing 
The SA refinement protocol as incorporated in X-PLOR (80) 
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was used for an additional round of crystallographic 
refinement. The maximum temperature was 1500 K. One round of 
SA refinement brought the R-factor down to 20.7 %. 
4.3.2.5.4 B-factor Refinement 
A final round of refinement involved refining the 
isotropic B-factors. B-factors are a measure of the 
displacement of an atom by thermal motion, conformational 
disorder, and static lattice disorder. The R-factor after one 
round of such refinement was 17.0 9.c 0. The error in the 
coordinates was estimated from the Luzzati plot (Appendix 3) 
as 0.25 A (85). 
4.3.2.6 Electron density map for ,B82XLHbA 
Figure 24(a) shows the electron density map where the Fo 
map is superimposed on the difference Fo-Fc map. This is the 
electron density in the area of the two Lysines-,882. The 
electron density due to the cross-linker is seen to extend 
from one Lysine-,882 to the other Lysine-,882. Onto this 
electron density map is superimposed the ,B82XLHbA model with 
the cross-linker. Figure 24(b) is a stereo diagram of the area 
around the cross-linker as described above. 
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Figure 24(a). Electron density map of ~82XLHbA in the region 
of the cross-linker. This is a 2Fo-Fc map. The atomic model 
is shown as thick lines. The density map is shown as thin 
lines. 
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Figure 24(b) Stereo pictures showing the region of the cross-
link between the two Lysines-~82. 
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4.3.2.7 Structural comparisons of fi82XLHbA with native deoxy 
hemoglobin (T-state) and with liganded hemoglobins (Rand R2 
states) 
Figures 25 a, b, c, d, e & f show therms deviation of 
the a and fi chain backbone of fi82XLHbA from the search model, 
deoxy HbA (46), the 2.1 A structure of oxy HbA (81, R-state 
structure, crystals grown from high phosphate salt solution 
concentrations) and carbonmonoxy HbA (82, R2-state structure, 
crystals grown from buffers of low salt concentration). 
Figures 25 g and h show therms deviation of the backbone 
deoxy HbA from that of oxy HbA. The overall deviation of deoxy 
HbA from oxy HbA is not very different from therms deviation 
of P82XLHbA from oxy HbA. 
The overall deviation in a chain backbone conformation 
of P82XLHbA from deoxy HbA is negligible. The p chain shows 
only a small deviation in the region local to the cross-
linker, the backbone does not deviate by greater than 2.0 A 
from the deoxy HbA structure. The EF loop, of which lysine-
ps2 is one residue, is pulled inward due to the cross-linking, 
Figures 26 and 27. This is the largest shift in backbone from 
the deoxy HbA. This shift gives the fi82XLHbA a more 'R-like' 
conformation. 
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Figure 25. RMS deviation of the a-chain (a) of ~82XLHbA shows 
little deviation from the a-chain of native deoxy HbA, while 
the rms deviation of the ~-chain (b) shows up to 2. 0 A. 
deviation from the ~-chain of native deoxy HbA. 
RMS deviation of the a-chain (c) to (f) of ~82XLHbA from 
the a-chain of oxy HbA (R-state) and HbA (R2-state) 
respectively. Here the major difference is in the region of 
the a 1~ 2 contact region spaning the residues 35-50. Therms 
deviation of the ~-chains is large thoughout due to the 
movement of the a~ dimer compared to that of deoxy HbA. 
Crystals of ~82XLHbA were grown under deoxy conditions. 
RMSD on the y-axis is in A. 
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Figure 25. contd. RMS deviation of the (g) a-chain and (h) ~-
chain of deoxy HbA from oxy HbA. 
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Figure 26. ~82XLHbA backbone superimposed on the backbone of 
deoxy HbA showing areas of overlap. ~82XLHbA is in thicker 
lines. Notice that the ~82XLHbA ~-chain backbones are closer 
in the ~-cleft region. 
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Figure 27. The superimposed ~-cleft region of ~82XLHbA (darker 
line) on deoxy HbA. The lysines-~82 of ~82XLHbA are closer to 
each other than the corresponding residues of native deoxy 
HbA. 
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The shift in the Ca of the Lys-,882s seems to travel 'up' the 
E-helix, particularly residues 75-84, leading to the largest, 
approximately 2.0 A, movement in the backbone conformation. 
There are also some changes observed in the F-helix. The 
movement of the E-helix leads to a slight movement of the 
distal histidine, His-,863, in relation to the Fe of the heme 
group. The distance between His-,8 163N€2 and the Fe of the heme 
in deoxy HbA is 4. 12 A. The corresponding distances in 
,882XLHbA and oxy HbA are 4. 20 A and 4 .19 A, respectively, 
Figure 28. This being the oxygen binding site, the movement 
of the distal histidine in ,882XLHbA towards the oxy 
conformation is probably what gives the ,882XLHbA derivative 
its high affinity for oxygen. The shift in backbone of 
residues 1 to 10, the A-helix, is probably to accomodate the 
movement of the EF loop. 
Figure 29 is a spectrum colored ,882XLHbA tetramer. The 
coloring indicates the movement of the various atoms and 
residues along the path T --> R. The color spectrum covers the 
range from blue to red with red indicating a more deoxy, T, 
like conformation and blue indicating a more oxy, R, like 
conformation. While most of the ,882XLHbA tetramer seems to 
retain its deoxy conformation, there are parts of the molecule 
seem to have moved towards the oxy conformation. Moreover, the 
oxygen affinity of ,882XLHbA is somewhat greater than that of 
native HbA, Table 20 (84). This might then be partly explained 
by the more R-like conformation of the ,882XLHbA even 
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Figure 28. The ~1 heme showing the proximal, the distal 
histidines and the Val-~98 for ~82XLHbA (darkest line), oxy 
HbA (lighter line) and deoxy HbA (lightest line). 
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Figure 29. Spectrum colored ~82XLHbA atomic model indicating 
the 'R-likeness' of the molecule. The R-likeness was 
calculated from the relation: 
R-likeness= 
Distance between Hb\ and fi82Hb; 
Distance between Hb1 ; and HbR; 
where Hb1; is the ith atom on deoxy HbA fi82Hb; is the ith atom 
on fi82XLHbA and HbR; is the ith atom on oxy-HbA. 
The color scheme ranges from red (T-like, deoxy) to blue (R-
like, oxy) 
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Table 20. Oxygen affinity {P50, mmHg) and Hill coefficients 
(84) 
HbA 
fJ82XLHbA 
a99XLHbA 
RBC 
P50 
9.6 ± 0.3 
7.4 ± 0.2 
14.9 ± 0.1 
27.1 ± 0.4 
n 
2.4 ± 0.1 
2.4 ± 0.1 
2.2 ± 0.1 
2.4 ± 0.1 
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in the deoxy state. 
Table 21 lists Ca distances between various residues 
present in the ;S-cleft region for ;382XLHbA, deoxy HbA (T-
state), oxy HbA (R-state) and carbonmomoxy HbA (R2-state). 
While the individual distances do not seem impressive, it is 
obvious that the cross-linker has pulled the two ;3 chains 
closer in the cross-linked derivative compared to the uncross-
linked native deoxy HbA. From the distances of the Ca atoms 
in fi82XLHbA when compared with the two liganded HbA's it is 
obvious that the cross-linked derivative still retains very 
much of its T-state conformation. 
The largest difference, besides the lysines-;382, is the 
distance between the iron atoms of the hemes on the ;S-chains 
also indicating a slight, but noticable movement of the fi-
chains, inwards. Table 22 lists the distances in A of the Fe 
atoms in the various HbA species mentioned above. The Fe atoms 
of the fi-hemes in the ;382XLHbA are 1. 1 A closer than the 
corresponding Fe atoms of native deoxy HbA. Again, the ;S-heme 
Fe-Fe distance in the derivative is still a long way off from 
that of the two liganded HbAs. 
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Table 21. Ca distances in A for residues in the {3-cleft region 
Deoxy HbA (T} HbA-O2 (R) HbA-CO (R2) {382XLHbA 
f3,-f32 His 143 18.60 12.42 10.94 17.56 
f3,-f32 His 2 21. 41 28.19 32.98 20.79 
f3,-f32 Lys 82 19.55 14.94 14.55 17.26 
f3 ,-f32 VAL 1 17.69 22.79 26.86 17.42 
f3,-f32 ASN 139 13.89 10.07 12.53 12.90 
f3,-f32 GLU 7 38.90 43.38 48.45 38.84 
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Table 22. Distances in A between the Fe atoms of the heme 
groups 
Deoxy HbA (T) HbA-02 (R) HbA-CO (R2) {382XLHbA 
a 1-a2 34.16 34.75 35.21 34.46 
f3 ,-f32 39.51 34.62 34.33 38.41 
a,-f3, 24.26 25.50 26.12 24.60 
a,-/32 36.49 34.72 34.49 35.79 
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The change in conformation of fi82XLHbA was examined by 
a graphical plot where the RMSD0xY-DEOXY - R.MSDoxY-t,82 was plotted 
against the residue number for each chain, Figure 30 {a) & 
(b). With rms deviations less than O. 3 A. being probably 
largely due to experimental error, the a-chain shows little 
or no deviation. The fi-chain shows specific areas where the 
difference between oxy HbA and deoxy HbA was greater than the 
difference between the oxy HbA and fi82XLHbA backbone 
conformation. The most pronounced of these are areas of the 
c-and D-helices, the E-helix and EF-loop, Figure 31. The A-
helix too shows significant movements from the deoxy 
structure. 
The introduction of the cross-link perturbs the solvent 
in the region of the fi-cleft. This leads to formation of new 
hydrogen bonds between residues and between residues and water 
molecules. There are eight molecules of water in the fi-cleft 
region of fi82XLHbA compared with six in native deoxy HbA. For 
example, nitrogen of Val-lfi 1 hydrogen bonds to Leu-78fi 1 in 
deoxy HbA, while in fi82XLHbA the same nitrogen is hydrogen 
bonded both to the leucine and to a molecule of water. In both 
species there is a water molecule bonded to the nitrogen of 
Asn-139fi 1 • However, while the carbonyl oxygen of Glu-136fi 1 
hydrogen bonds to the nitrogen of Ala-140fi 1 , the corresponding 
Glu-136fi 1 forms no noticable hydrogen bonds in fi82XLHbA. 
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Figure 30. (a} Difference RMSD (A) of the a-chains and (b) 
Difference RMSD (A) of the ~-chains of ~82XLHbA and oxy-HbA. 
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Figure 31. Significant backbone movements in (a) the C-helix 
(38-42), D-helix (50-57), E-helix (58-77), EF-loop (78-85) and 
the F-helix (86-95). 
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5. CONCLUSIONS 
Crystallographic studies on the two chemically cross-
linked hemoglobins studies revealed changes in the structure 
that were linked to properties of these hemoglobins. Both 
hemoglobin derivatives behave differently when compared with 
native hemoglobin. Some of the changes, like stability of the 
quarternary structure, can be attributed to the covalent 
linkage of the subunits. However, the changes in the oxygen 
binding properties of the cross-linked derivatives seem to be 
only due to subtle changes in portions of the molecular 
structure. 
The a99XLHbA showed no significant changes in the 
backbone structure from native deoxy HbA. The only changes 
observed were in the side chains of the cross-linked Lys-a99s, 
the Glu-p101s and the Arg-~104s. None of these changes was 
large enough to indicate that they would have an effect on the 
oxygen binding properties of a99XLHbA. Yet, a99XLHbA shows 
remarkably low affinity for oxygen, Table 20. There was no 
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evidence that the cross-link had stabilized the T-state deoxy 
conformer. The modification must then affect the oxy, R-$tate, 
conformer so as to destabilize it. A destabilized oxy 
conformer would then lead to a smaller propensity for oxygen 
binding. 
P82XLHbA, on the other hand, is a high affinity cross-
linked hemoglobin. The changes observed in the structure in 
this derivative were large enough to explain its oxygen-
binding properties. Unlike a99XLHbA, cross-linking between the 
Lys-P82 leads to movements in the backbone of the p-chains 
that prevent it from completely reaching the T-state. Due to 
the cross-link, the E-helix, the EF-loop, and the F-helix, all 
stay close to their relative positions in oxy HbA and do not 
move to their corresponding positions in deoxy HbA. The oxy-
like conformations are observed in helices as far as the c-
and D-helices. 
The largest movement towards the oxy-state is observed 
in the E-helix. This has an effect on the position of the 
distal histidine, His-p63, of the p-chains relative to the Fe 
of the p-hemes. This is the p-chain oxygen binding site and 
the movement of the His-fi63 in fi82XLHbA away from the Fe atom 
and towards the position of the corresponding histidine in oxy 
hemoglobin, is a strong indication of the oxy-like structure 
of P82XLHbA. The movement of the residues in the p-cleft of 
P82XLHbA and the movement of the p-chain distal histidine away 
from the heme would then explain the high oxygen affinity 
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observed. 
Therefore, while the ~82XLHbA has a stable quarternary 
structure, it would make a poor red-cell substitute due to 
the large oxygen affinity. 
APPENDIX 
1 
The following is the topology file describing the 
fumarate cross-linker and the linkage of the cross-linker to 
the Lys-a99N1s for the patch job in X-PLOR. 
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&& 
remarks topology file for bisfurnarate and singly protonated 
remarks lysine residues 
AUTOGENERATE ANGLES=TRUE END 
HA 1.00800! aliphatic hydrogen 
C 12.01100! carbonyl carbon 
o 15.99940! carbonyl oxygen 
CRlE 13.01900! ="= ="= in an aromatic 
with one H 
MASS 
MASS 
MASS 
MASS 
ring 
MASS 
MASS 
MASS 
CH2E 14.02700 ! 11 
NH3 14.00670 ! nitrogen bound to 
H 1.00800 ! hydrogen which can 
two hydrogens 
three hydrogens 
h-bond to neutral 
atom 
!CB here is the same as CRlE of tophcsdx.pro 
•------------------------------------------------------' . . 
RESidue FRAG 
GROUp 
ATOM Cl TYPE=CRlE CHARge= 0.00 END !# 
ATOM cs TYPE=CRlE CHARge= 0.00 END !# 
ATOM Hl TYPE=H CHARGe= 0.00 END !# 
ATOM HS TYPE=H CHARGe= 0.00 END !# 
GROUp 
ATOM C2 TYPE=C CHARge= 0.55 END !# 
ATOM C7 TYPE=C CHARge= 0.55 END !# 
ATOM 03 TYPE=O CHARge=-0.55 END !# 
ATOM 08 TYPE=O CHARge=-0.55 END !# 
BOND 03 C2 
BOND C2 Cl 
BOND Cl C5 
BOND cs C7 
BOND C7 08 
BOND Cl Hl 
BOND cs HS 
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{} 
IMPROPER Cl C2 C5 Hl IMPROPER C5 Cl C7 H5 
IMPROPER 08 C7 cs Cl IMPROPER 03 C2 Cl C5 
{* 
DIHE 03 C2 Cl C5 DIHE Cl C5 C7 08 
DIHE C2 Cl C5 C7 DIHE 03 C2 Cl Hl DIHE Hl Cl C5 H5 
DIHE H5 C5 C7 08 
{} 
IC C2 Cl C5 C7 0.0000 0.00 180.00 0.00 0.0000 
*} 
END {FRAG} 
!-------------------------! 
PRESidue PFRA ! Patch for FRAG. Patch residues must be 1-LYS, 
and 2-FRAG. 
group 
modify atom lNZ type NHl charge -.35 end 
delete atom 1HZ2 end 
delete atom 1HZ3 end 
modify atom lHZl type H charge 0.25 end 
modify atom lCD type CH2E charge 0.70 end 
group 
add bond lNZ 2C2 
add angle 2C2 lNZ lHZl 
add improper 2C2 2Cl 203 lNZ 
add improper lNZ lCD lHZl 2C2 
END {PFRA} 
PRESIDUE PFRB 
group 
atom 
atom 
atom 
modify 
delete 
delete 
modify atom 
modify atom 
group 
lNZ type NHl charge -.35 end 
1HZ2 end 
1HZ3 end 
lHZl type H charge 0.25 end 
lCD type CH2E charge 0.70 end 
add bond lNZ 2C7 
add angle 2C7 lNZ lHZl 
add improper 2C7 2C5 208 lNZ 
add improper lNZ lCD lHZl 2C7 
END {PFRB} 
•---------------------------------------------------' . . 
SET ECHO=TRUE END 
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2 
RMSD plots of a99XLHbA versus native deoxy HbA. (a) a-chain 
backbone, (b) a-chain sidechain, (c) p-chain backbone and (d) 
p-chain sidechain. 
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3 
Luzzati plot {85) of fi82XLHbA coordinates showing an average 
error in coordinates, ~r = 0.25 A. 
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